Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Synthetic Biology | 36 | 2023 | 179 | 10.430 |
Why?
|
Schistosoma mansoni | 19 | 2021 | 149 | 8.040 |
Why?
|
Anti-Bacterial Agents | 57 | 2023 | 7182 | 7.420 |
Why?
|
Escherichia coli | 61 | 2022 | 4217 | 7.420 |
Why?
|
Genetic Engineering | 35 | 2022 | 951 | 6.100 |
Why?
|
Occupational Exposure | 55 | 2020 | 1793 | 5.940 |
Why?
|
Bacteria | 30 | 2022 | 2115 | 5.090 |
Why?
|
Gene Regulatory Networks | 43 | 2023 | 1707 | 4.880 |
Why?
|
Chemical Industry | 33 | 2018 | 114 | 4.340 |
Why?
|
Helminth Proteins | 10 | 2021 | 171 | 4.280 |
Why?
|
Drug Resistance, Bacterial | 15 | 2022 | 1035 | 3.330 |
Why?
|
Styrene | 7 | 2020 | 24 | 3.280 |
Why?
|
Systems Biology | 15 | 2020 | 469 | 2.990 |
Why?
|
Schistosomiasis mansoni | 7 | 2020 | 85 | 2.900 |
Why?
|
Occupational Diseases | 33 | 2020 | 1469 | 2.880 |
Why?
|
Microbial Viability | 14 | 2021 | 234 | 2.880 |
Why?
|
Planarians | 9 | 2022 | 52 | 2.810 |
Why?
|
Models, Genetic | 31 | 2016 | 3493 | 2.450 |
Why?
|
Dioxins | 10 | 2016 | 102 | 2.200 |
Why?
|
Bacterial Physiological Phenomena | 7 | 2020 | 121 | 2.140 |
Why?
|
Drug Discovery | 8 | 2023 | 1058 | 2.090 |
Why?
|
Biosensing Techniques | 8 | 2021 | 668 | 2.060 |
Why?
|
Microbial Sensitivity Tests | 18 | 2023 | 1877 | 1.980 |
Why?
|
Schistosoma | 4 | 2023 | 17 | 1.950 |
Why?
|
Gene Expression Regulation, Bacterial | 20 | 2020 | 1122 | 1.930 |
Why?
|
Chlorophenols | 8 | 2012 | 16 | 1.840 |
Why?
|
Gene Expression Regulation | 36 | 2023 | 12073 | 1.690 |
Why?
|
Escherichia coli Proteins | 16 | 2022 | 1050 | 1.670 |
Why?
|
Acrylonitrile | 12 | 2012 | 21 | 1.640 |
Why?
|
Drug Resistance, Microbial | 6 | 2014 | 862 | 1.560 |
Why?
|
Saccharomyces cerevisiae | 15 | 2019 | 2751 | 1.450 |
Why?
|
Postural Balance | 14 | 2006 | 620 | 1.450 |
Why?
|
Genes, Synthetic | 7 | 2019 | 90 | 1.430 |
Why?
|
Carcinogens | 13 | 2018 | 466 | 1.430 |
Why?
|
Biofilms | 9 | 2020 | 617 | 1.420 |
Why?
|
Ampicillin | 6 | 2022 | 139 | 1.370 |
Why?
|
Bacterial Infections | 8 | 2018 | 1401 | 1.360 |
Why?
|
Leukemia | 8 | 2015 | 1510 | 1.350 |
Why?
|
Anthelmintics | 4 | 2023 | 62 | 1.340 |
Why?
|
Posture | 15 | 2017 | 958 | 1.330 |
Why?
|
Escherichia coli Infections | 7 | 2021 | 532 | 1.320 |
Why?
|
Genetic Techniques | 4 | 2020 | 435 | 1.310 |
Why?
|
Genome, Bacterial | 8 | 2022 | 760 | 1.300 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2020 | 214 | 1.290 |
Why?
|
Schistosomiasis | 5 | 2024 | 62 | 1.290 |
Why?
|
Animals | 163 | 2024 | 168768 | 1.290 |
Why?
|
DNA, Bacterial | 8 | 2018 | 1465 | 1.260 |
Why?
|
Plasmids | 10 | 2022 | 2308 | 1.260 |
Why?
|
Transcription, Genetic | 26 | 2021 | 7721 | 1.260 |
Why?
|
Platyhelminths | 2 | 2018 | 9 | 1.250 |
Why?
|
Pluripotent Stem Cells | 7 | 2017 | 795 | 1.240 |
Why?
|
Pathology, Molecular | 3 | 2020 | 326 | 1.230 |
Why?
|
Bioengineering | 4 | 2012 | 99 | 1.230 |
Why?
|
Stochastic Processes | 23 | 2016 | 344 | 1.220 |
Why?
|
Protein Biosynthesis | 7 | 2021 | 2126 | 1.210 |
Why?
|
Containment of Biohazards | 2 | 2018 | 37 | 1.180 |
Why?
|
Stem Cells | 10 | 2020 | 3567 | 1.180 |
Why?
|
Computational Biology | 16 | 2020 | 3519 | 1.180 |
Why?
|
Benzofurans | 4 | 2009 | 140 | 1.180 |
Why?
|
Norfloxacin | 5 | 2015 | 25 | 1.180 |
Why?
|
Kanamycin | 4 | 2015 | 64 | 1.170 |
Why?
|
Formaldehyde | 9 | 2010 | 353 | 1.140 |
Why?
|
Carbon | 4 | 2022 | 687 | 1.100 |
Why?
|
Parasites | 3 | 2022 | 163 | 1.100 |
Why?
|
Benzene | 6 | 2015 | 100 | 1.080 |
Why?
|
Reactive Oxygen Species | 9 | 2022 | 2076 | 1.070 |
Why?
|
RNA | 12 | 2023 | 2749 | 1.060 |
Why?
|
Drug Tolerance | 3 | 2019 | 376 | 1.060 |
Why?
|
Bacteriophages | 3 | 2015 | 356 | 1.050 |
Why?
|
Gram-Negative Bacteria | 2 | 2019 | 271 | 1.010 |
Why?
|
Cell Physiological Phenomena | 3 | 2018 | 154 | 1.000 |
Why?
|
Adult Stem Cells | 3 | 2017 | 216 | 0.980 |
Why?
|
Oxidative Stress | 10 | 2017 | 3084 | 0.970 |
Why?
|
Peritonitis | 2 | 2017 | 365 | 0.970 |
Why?
|
Host-Parasite Interactions | 2 | 2017 | 295 | 0.970 |
Why?
|
Bacterial Proteins | 13 | 2022 | 3854 | 0.960 |
Why?
|
Toluene 2,4-Diisocyanate | 3 | 2017 | 10 | 0.950 |
Why?
|
Models, Biological | 29 | 2018 | 9584 | 0.940 |
Why?
|
Lactococcus lactis | 3 | 2018 | 28 | 0.940 |
Why?
|
Communicable Diseases | 2 | 2023 | 880 | 0.930 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2016 | 362 | 0.920 |
Why?
|
Riboswitch | 2 | 2020 | 12 | 0.910 |
Why?
|
Nucleic Acids | 3 | 2023 | 182 | 0.890 |
Why?
|
RNA Interference | 12 | 2020 | 2890 | 0.880 |
Why?
|
Citric Acid Cycle | 4 | 2021 | 232 | 0.880 |
Why?
|
Muscular Dystrophies | 6 | 2017 | 393 | 0.870 |
Why?
|
DNA | 10 | 2022 | 7294 | 0.870 |
Why?
|
Feces | 8 | 2022 | 1401 | 0.860 |
Why?
|
DNA Damage | 10 | 2022 | 2432 | 0.860 |
Why?
|
Drug Resistance, Multiple, Bacterial | 4 | 2023 | 567 | 0.850 |
Why?
|
Genomics | 12 | 2023 | 5717 | 0.850 |
Why?
|
Amdinocillin | 1 | 2022 | 7 | 0.840 |
Why?
|
Cause of Death | 24 | 2018 | 3582 | 0.840 |
Why?
|
Candida albicans | 2 | 2017 | 394 | 0.840 |
Why?
|
Genes, Bacterial | 6 | 2021 | 1079 | 0.840 |
Why?
|
RNA Editing | 2 | 2023 | 148 | 0.840 |
Why?
|
Pentachlorophenol | 5 | 2009 | 10 | 0.830 |
Why?
|
Promoter Regions, Genetic | 14 | 2017 | 5867 | 0.820 |
Why?
|
Humans | 336 | 2024 | 744366 | 0.820 |
Why?
|
Endodeoxyribonucleases | 2 | 2020 | 165 | 0.810 |
Why?
|
Pheromones | 1 | 2022 | 97 | 0.810 |
Why?
|
Signal Transduction | 24 | 2019 | 23404 | 0.800 |
Why?
|
Staining and Labeling | 2 | 2020 | 1101 | 0.800 |
Why?
|
Green Fluorescent Proteins | 8 | 2018 | 2088 | 0.790 |
Why?
|
Transcriptional Activation | 6 | 2015 | 1783 | 0.790 |
Why?
|
Gene Expression | 10 | 2020 | 7798 | 0.790 |
Why?
|
Salmonella typhimurium | 2 | 2013 | 351 | 0.780 |
Why?
|
Caenorhabditis elegans | 10 | 2022 | 1418 | 0.780 |
Why?
|
DNA Transposable Elements | 2 | 2023 | 748 | 0.770 |
Why?
|
Enterococcus faecium | 1 | 2022 | 102 | 0.770 |
Why?
|
Paper | 2 | 2018 | 85 | 0.770 |
Why?
|
Air Pollutants, Occupational | 7 | 2017 | 408 | 0.770 |
Why?
|
Basic Reproduction Number | 1 | 2020 | 31 | 0.770 |
Why?
|
Penicillin-Binding Proteins | 1 | 2022 | 137 | 0.760 |
Why?
|
Germ Cells | 4 | 2017 | 631 | 0.760 |
Why?
|
Genome | 5 | 2018 | 1807 | 0.750 |
Why?
|
Aminoglycosides | 4 | 2021 | 162 | 0.750 |
Why?
|
Operon | 2 | 2021 | 363 | 0.750 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2012 | 436 | 0.740 |
Why?
|
Blood | 2 | 2020 | 598 | 0.740 |
Why?
|
Engineering | 2 | 2023 | 58 | 0.740 |
Why?
|
Polychlorinated Biphenyls | 5 | 2014 | 245 | 0.740 |
Why?
|
Oxidation-Reduction | 6 | 2016 | 2184 | 0.730 |
Why?
|
Quinolones | 5 | 2017 | 367 | 0.730 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2020 | 118 | 0.730 |
Why?
|
Eukaryotic Cells | 4 | 2013 | 198 | 0.730 |
Why?
|
Gene Expression Regulation, Developmental | 8 | 2017 | 3617 | 0.730 |
Why?
|
Thiadiazoles | 1 | 2020 | 55 | 0.720 |
Why?
|
Gene Expression Regulation, Fungal | 6 | 2019 | 502 | 0.720 |
Why?
|
Cell Respiration | 2 | 2017 | 201 | 0.710 |
Why?
|
Life Cycle Stages | 3 | 2021 | 160 | 0.700 |
Why?
|
Organisms, Genetically Modified | 2 | 2018 | 64 | 0.700 |
Why?
|
Staphylococcus aureus | 7 | 2023 | 1453 | 0.700 |
Why?
|
Biosynthetic Pathways | 1 | 2020 | 137 | 0.700 |
Why?
|
RNA, Messenger | 17 | 2021 | 13035 | 0.700 |
Why?
|
Mice | 68 | 2024 | 81201 | 0.700 |
Why?
|
Collagen Type VI | 6 | 2017 | 26 | 0.690 |
Why?
|
Protein Engineering | 5 | 2016 | 538 | 0.690 |
Why?
|
Multigene Family | 2 | 2020 | 1102 | 0.680 |
Why?
|
RNA, Bacterial | 6 | 2014 | 390 | 0.680 |
Why?
|
Transcription Factors | 17 | 2023 | 12207 | 0.680 |
Why?
|
Micronucleus Tests | 1 | 2018 | 23 | 0.670 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 323 | 0.670 |
Why?
|
Oxygen Consumption | 3 | 2015 | 1868 | 0.660 |
Why?
|
Musa | 1 | 2018 | 12 | 0.650 |
Why?
|
Biological Evolution | 3 | 2022 | 1077 | 0.650 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2018 | 38 | 0.650 |
Why?
|
Cefuroxime | 7 | 1996 | 23 | 0.650 |
Why?
|
Gram-Positive Bacteria | 1 | 2019 | 185 | 0.640 |
Why?
|
Gene Expression Profiling | 20 | 2020 | 9445 | 0.640 |
Why?
|
Cell-Free System | 2 | 2016 | 344 | 0.620 |
Why?
|
Aging | 15 | 2023 | 8664 | 0.620 |
Why?
|
Metabolome | 4 | 2017 | 895 | 0.610 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 578 | 0.610 |
Why?
|
Plasmodium | 1 | 2020 | 250 | 0.600 |
Why?
|
Hydroxyl Radical | 5 | 2013 | 78 | 0.600 |
Why?
|
Lymphoma | 3 | 2014 | 1877 | 0.600 |
Why?
|
Probiotics | 3 | 2018 | 351 | 0.600 |
Why?
|
Population Surveillance | 5 | 2017 | 2616 | 0.590 |
Why?
|
Opportunistic Infections | 1 | 2020 | 389 | 0.580 |
Why?
|
Neoplasms | 31 | 2021 | 21696 | 0.580 |
Why?
|
Lactobacillus | 3 | 2018 | 189 | 0.580 |
Why?
|
Laminin | 5 | 2017 | 419 | 0.580 |
Why?
|
Cell Membrane | 6 | 2021 | 3749 | 0.580 |
Why?
|
Pseudomonas aeruginosa | 2 | 2017 | 1219 | 0.580 |
Why?
|
RNA, Untranslated | 2 | 2015 | 453 | 0.580 |
Why?
|
Mutation | 27 | 2022 | 29786 | 0.570 |
Why?
|
Enzymes | 1 | 2018 | 266 | 0.570 |
Why?
|
Carrier State | 1 | 2020 | 518 | 0.570 |
Why?
|
Cell Differentiation | 24 | 2023 | 11486 | 0.570 |
Why?
|
Vitellins | 1 | 2016 | 1 | 0.570 |
Why?
|
Algorithms | 14 | 2023 | 13882 | 0.570 |
Why?
|
Metabolic Networks and Pathways | 3 | 2019 | 783 | 0.570 |
Why?
|
Communicable Disease Control | 1 | 2023 | 856 | 0.560 |
Why?
|
Molecular Biology | 3 | 2021 | 596 | 0.560 |
Why?
|
Cytoplasm | 1 | 2021 | 1536 | 0.560 |
Why?
|
Biotechnology | 4 | 2018 | 281 | 0.550 |
Why?
|
Proteins | 5 | 2022 | 6100 | 0.550 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 974 | 0.550 |
Why?
|
Epigenomics | 2 | 2021 | 903 | 0.540 |
Why?
|
Environmental Pollutants | 5 | 2009 | 1179 | 0.540 |
Why?
|
Repressor Proteins | 12 | 2018 | 3024 | 0.540 |
Why?
|
Malaria | 3 | 2024 | 1239 | 0.540 |
Why?
|
Metagenome | 4 | 2013 | 418 | 0.540 |
Why?
|
Proprioception | 6 | 2003 | 132 | 0.540 |
Why?
|
Esophagus | 2 | 2021 | 1019 | 0.540 |
Why?
|
Benchmarking | 1 | 2022 | 1042 | 0.530 |
Why?
|
Epigenesis, Genetic | 8 | 2020 | 3646 | 0.530 |
Why?
|
Gait | 8 | 2000 | 793 | 0.520 |
Why?
|
Retinal Pigments | 1 | 2015 | 83 | 0.520 |
Why?
|
Species Specificity | 9 | 2019 | 2478 | 0.520 |
Why?
|
Mutagenesis | 5 | 2018 | 1264 | 0.520 |
Why?
|
Toxins, Biological | 1 | 2015 | 66 | 0.520 |
Why?
|
Ocular Physiological Phenomena | 1 | 2015 | 70 | 0.520 |
Why?
|
Vinyl Chloride | 1 | 2014 | 15 | 0.510 |
Why?
|
Tryptophan Hydroxylase | 1 | 2015 | 89 | 0.510 |
Why?
|
Muscular Dystrophy, Duchenne | 4 | 2022 | 256 | 0.500 |
Why?
|
RNA, Catalytic | 2 | 2012 | 50 | 0.500 |
Why?
|
Mammals | 6 | 2023 | 1143 | 0.500 |
Why?
|
Zinc Fingers | 3 | 2015 | 583 | 0.500 |
Why?
|
Embryonic Stem Cells | 8 | 2020 | 1295 | 0.500 |
Why?
|
MutS DNA Mismatch-Binding Protein | 1 | 2014 | 11 | 0.500 |
Why?
|
2,4,5-Trichlorophenoxyacetic Acid | 3 | 2009 | 12 | 0.500 |
Why?
|
Touch | 3 | 2003 | 306 | 0.490 |
Why?
|
Genome, Viral | 2 | 2020 | 667 | 0.490 |
Why?
|
Parasitology | 2 | 2011 | 29 | 0.480 |
Why?
|
Mitochondria | 4 | 2017 | 3514 | 0.480 |
Why?
|
Michigan | 8 | 2015 | 350 | 0.480 |
Why?
|
Alanine | 2 | 2021 | 572 | 0.470 |
Why?
|
Hydrogels | 1 | 2019 | 724 | 0.470 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1813 | 0.470 |
Why?
|
Catalase | 1 | 2014 | 221 | 0.470 |
Why?
|
Stress, Physiological | 4 | 2016 | 1403 | 0.470 |
Why?
|
Polysaccharides | 1 | 2020 | 1059 | 0.470 |
Why?
|
Computer Simulation | 12 | 2017 | 6194 | 0.460 |
Why?
|
Heart Valve Prosthesis | 19 | 1998 | 1490 | 0.460 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2018 | 1887 | 0.460 |
Why?
|
Prokaryotic Cells | 1 | 2013 | 48 | 0.450 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2015 | 264 | 0.450 |
Why?
|
Gene Dosage | 2 | 2016 | 1252 | 0.450 |
Why?
|
Male | 164 | 2022 | 350115 | 0.450 |
Why?
|
Oxygen | 6 | 2017 | 4189 | 0.450 |
Why?
|
Melanins | 1 | 2015 | 289 | 0.450 |
Why?
|
Respiratory Tract Neoplasms | 3 | 2006 | 57 | 0.450 |
Why?
|
Female | 156 | 2023 | 380193 | 0.450 |
Why?
|
Single-Cell Analysis | 6 | 2021 | 2182 | 0.450 |
Why?
|
MicroRNAs | 9 | 2022 | 3751 | 0.440 |
Why?
|
RNA, Viral | 6 | 2023 | 2901 | 0.440 |
Why?
|
Histones | 4 | 2022 | 2598 | 0.440 |
Why?
|
Superoxides | 2 | 2013 | 387 | 0.440 |
Why?
|
Hematopoietic Stem Cells | 8 | 2024 | 3390 | 0.440 |
Why?
|
Ethosuximide | 3 | 2008 | 9 | 0.430 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2022 | 2949 | 0.430 |
Why?
|
Genes, Helminth | 4 | 2020 | 147 | 0.430 |
Why?
|
Silver | 1 | 2013 | 122 | 0.430 |
Why?
|
Occupational Health | 6 | 2017 | 808 | 0.430 |
Why?
|
Biocompatible Materials | 2 | 2019 | 1736 | 0.430 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1678 | 0.430 |
Why?
|
Antibody Formation | 3 | 2016 | 1402 | 0.420 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 239 | 0.420 |
Why?
|
Induced Pluripotent Stem Cells | 8 | 2023 | 1736 | 0.420 |
Why?
|
Vestibule, Labyrinth | 3 | 2001 | 235 | 0.420 |
Why?
|
Pain, Intractable | 3 | 1999 | 130 | 0.410 |
Why?
|
Vaccines | 2 | 2021 | 823 | 0.410 |
Why?
|
Ciprofloxacin | 3 | 2021 | 315 | 0.410 |
Why?
|
Feedback, Physiological | 6 | 2021 | 479 | 0.410 |
Why?
|
Diabetic Neuropathies | 3 | 2006 | 400 | 0.410 |
Why?
|
Accidents, Occupational | 3 | 2003 | 251 | 0.410 |
Why?
|
Vibrio cholerae | 1 | 2018 | 807 | 0.410 |
Why?
|
Apoptosis | 6 | 2017 | 9724 | 0.400 |
Why?
|
Lymphoma, Non-Hodgkin | 6 | 2018 | 1381 | 0.400 |
Why?
|
Hydrogen Sulfide | 2 | 2014 | 137 | 0.400 |
Why?
|
Inhalation Exposure | 4 | 2019 | 443 | 0.400 |
Why?
|
Body Patterning | 1 | 2016 | 626 | 0.400 |
Why?
|
Phosgene | 1 | 2011 | 2 | 0.400 |
Why?
|
Prodrugs | 5 | 1996 | 268 | 0.400 |
Why?
|
Reproduction | 5 | 2019 | 668 | 0.400 |
Why?
|
Chromatin | 4 | 2020 | 2933 | 0.400 |
Why?
|
Regeneration | 3 | 2017 | 1485 | 0.400 |
Why?
|
Cholera | 1 | 2018 | 785 | 0.400 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2725 | 0.390 |
Why?
|
Vestibular Nerve | 2 | 2002 | 101 | 0.390 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2013 | 232 | 0.390 |
Why?
|
Gentamicins | 1 | 2012 | 255 | 0.390 |
Why?
|
Agrochemicals | 2 | 2018 | 10 | 0.390 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.390 |
Why?
|
Directed Molecular Evolution | 2 | 2023 | 160 | 0.390 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2213 | 0.380 |
Why?
|
Cells | 3 | 2019 | 168 | 0.380 |
Why?
|
Laboratories | 1 | 2014 | 463 | 0.380 |
Why?
|
Mutagenesis, Insertional | 3 | 2023 | 655 | 0.380 |
Why?
|
Cephalosporins | 3 | 1996 | 204 | 0.370 |
Why?
|
Clostridium Infections | 1 | 2017 | 548 | 0.370 |
Why?
|
Acinetobacter baumannii | 2 | 2023 | 107 | 0.370 |
Why?
|
Gene Transfer, Horizontal | 4 | 2018 | 145 | 0.370 |
Why?
|
Gene Silencing | 4 | 2018 | 1539 | 0.370 |
Why?
|
Ribonucleotides | 1 | 2010 | 117 | 0.360 |
Why?
|
Mitral Valve | 14 | 1998 | 1491 | 0.360 |
Why?
|
Sensory Receptor Cells | 2 | 2008 | 493 | 0.360 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2219 | 0.360 |
Why?
|
Noise | 2 | 2002 | 279 | 0.360 |
Why?
|
Neurons, Afferent | 4 | 2002 | 506 | 0.360 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2020 | 186 | 0.360 |
Why?
|
Peptides | 1 | 2022 | 4410 | 0.350 |
Why?
|
Peptide Hormones | 1 | 2010 | 134 | 0.350 |
Why?
|
Drug Therapy, Combination | 9 | 2020 | 6489 | 0.350 |
Why?
|
Acrylic Resins | 2 | 2020 | 142 | 0.350 |
Why?
|
Mitochondrial Myopathies | 1 | 2009 | 47 | 0.350 |
Why?
|
Phenotype | 12 | 2023 | 16367 | 0.350 |
Why?
|
Hydrogen Peroxide | 5 | 2014 | 730 | 0.350 |
Why?
|
Escherichia coli K12 | 1 | 2009 | 34 | 0.350 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1970 | 0.340 |
Why?
|
History, 20th Century | 8 | 2014 | 2740 | 0.340 |
Why?
|
DNA-Binding Proteins | 11 | 2020 | 9647 | 0.340 |
Why?
|
Recombinases | 1 | 2009 | 67 | 0.340 |
Why?
|
Luminescent Proteins | 4 | 2018 | 853 | 0.340 |
Why?
|
Coronary Artery Bypass | 18 | 1999 | 2288 | 0.340 |
Why?
|
Fungal Proteins | 3 | 2017 | 912 | 0.340 |
Why?
|
Tissue Engineering | 1 | 2019 | 1880 | 0.340 |
Why?
|
Thymidine Kinase | 1 | 2009 | 290 | 0.340 |
Why?
|
Anticonvulsants | 3 | 2008 | 1916 | 0.330 |
Why?
|
Aminobiphenyl Compounds | 3 | 1999 | 5 | 0.330 |
Why?
|
Fibrinogen | 1 | 2012 | 894 | 0.330 |
Why?
|
Microscopy, Fluorescence | 5 | 2021 | 2700 | 0.330 |
Why?
|
Vaccines, Synthetic | 1 | 2011 | 634 | 0.330 |
Why?
|
Biodiversity | 2 | 2015 | 341 | 0.320 |
Why?
|
Drug Design | 3 | 2020 | 1076 | 0.320 |
Why?
|
Pancreatic Neoplasms | 3 | 2014 | 5263 | 0.320 |
Why?
|
Mortality | 6 | 2018 | 2864 | 0.320 |
Why?
|
Endogenous Retroviruses | 2 | 2022 | 112 | 0.320 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.320 |
Why?
|
Base Sequence | 8 | 2020 | 12797 | 0.320 |
Why?
|
Biomarkers, Pharmacological | 1 | 2009 | 162 | 0.320 |
Why?
|
Antifungal Agents | 1 | 2013 | 729 | 0.320 |
Why?
|
Lifting | 3 | 2007 | 56 | 0.310 |
Why?
|
Guanosine Tetraphosphate | 1 | 2007 | 11 | 0.310 |
Why?
|
Anaerobiosis | 2 | 2022 | 140 | 0.310 |
Why?
|
Muscle, Skeletal | 9 | 2018 | 4925 | 0.310 |
Why?
|
Muscle Proteins | 4 | 2020 | 1158 | 0.310 |
Why?
|
Employee Performance Appraisal | 2 | 2005 | 87 | 0.310 |
Why?
|
Bacteriophage T3 | 1 | 2007 | 2 | 0.310 |
Why?
|
Molecular Sequence Data | 11 | 2014 | 18111 | 0.310 |
Why?
|
Genes, Switch | 1 | 2007 | 47 | 0.310 |
Why?
|
Epidemiologic Studies | 4 | 2018 | 676 | 0.310 |
Why?
|
Walking | 8 | 2003 | 1180 | 0.300 |
Why?
|
History, 21st Century | 5 | 2014 | 1534 | 0.300 |
Why?
|
Dengue | 3 | 2022 | 256 | 0.300 |
Why?
|
Graft Rejection | 5 | 2020 | 4397 | 0.300 |
Why?
|
Absenteeism | 3 | 2007 | 250 | 0.300 |
Why?
|
Disease Models, Animal | 11 | 2023 | 18034 | 0.300 |
Why?
|
Industry | 4 | 2007 | 365 | 0.300 |
Why?
|
Lung Neoplasms | 13 | 2019 | 13104 | 0.300 |
Why?
|
Myopathies, Structural, Congenital | 2 | 2018 | 102 | 0.300 |
Why?
|
Morphine | 3 | 1996 | 657 | 0.300 |
Why?
|
Pseudomonas Infections | 1 | 2011 | 613 | 0.290 |
Why?
|
Risk | 11 | 2018 | 9688 | 0.290 |
Why?
|
United States | 39 | 2023 | 69872 | 0.290 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2007 | 87 | 0.290 |
Why?
|
Point-of-Care Systems | 3 | 2021 | 1178 | 0.290 |
Why?
|
Drug Interactions | 4 | 2021 | 1460 | 0.290 |
Why?
|
In Situ Hybridization | 4 | 2020 | 1950 | 0.290 |
Why?
|
Epidemiology | 2 | 2007 | 287 | 0.280 |
Why?
|
Time Factors | 28 | 2023 | 40075 | 0.280 |
Why?
|
Transportation of Patients | 2 | 2007 | 185 | 0.280 |
Why?
|
Indoles | 2 | 2012 | 1839 | 0.280 |
Why?
|
Models, Theoretical | 7 | 2019 | 3589 | 0.280 |
Why?
|
Sensation Disorders | 2 | 2006 | 156 | 0.280 |
Why?
|
Infant, Low Birth Weight | 1 | 2011 | 850 | 0.280 |
Why?
|
DNA Methylation | 3 | 2016 | 4285 | 0.280 |
Why?
|
Logic | 3 | 2019 | 39 | 0.270 |
Why?
|
Glutaral | 1 | 2006 | 78 | 0.270 |
Why?
|
Viral Proteins | 6 | 2009 | 1900 | 0.270 |
Why?
|
Adult | 90 | 2020 | 214052 | 0.270 |
Why?
|
Cell Proliferation | 6 | 2019 | 10483 | 0.270 |
Why?
|
Microbial Interactions | 2 | 2018 | 76 | 0.270 |
Why?
|
Genes, tat | 1 | 2005 | 15 | 0.270 |
Why?
|
Environmental Exposure | 8 | 2019 | 4232 | 0.270 |
Why?
|
Carbohydrates | 1 | 2008 | 394 | 0.270 |
Why?
|
Bacteriophage T7 | 1 | 2007 | 174 | 0.270 |
Why?
|
Cell Membrane Permeability | 2 | 2021 | 590 | 0.270 |
Why?
|
Feedback | 5 | 2002 | 795 | 0.270 |
Why?
|
Piracetam | 1 | 2006 | 87 | 0.260 |
Why?
|
Lab-On-A-Chip Devices | 3 | 2022 | 428 | 0.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2014 | 3921 | 0.260 |
Why?
|
Ecosystem | 3 | 2023 | 474 | 0.260 |
Why?
|
Vibration | 2 | 2006 | 326 | 0.260 |
Why?
|
Lac Repressors | 3 | 2016 | 15 | 0.260 |
Why?
|
Ribosomal Proteins | 1 | 2007 | 360 | 0.260 |
Why?
|
Hydroxyurea | 3 | 2014 | 289 | 0.260 |
Why?
|
Virulence | 2 | 2020 | 1333 | 0.260 |
Why?
|
Gene Knockdown Techniques | 3 | 2021 | 1656 | 0.250 |
Why?
|
Symbiosis | 2 | 2020 | 287 | 0.250 |
Why?
|
In Situ Nick-End Labeling | 2 | 2019 | 644 | 0.250 |
Why?
|
Brain Neoplasms | 6 | 2014 | 8861 | 0.250 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1352 | 0.250 |
Why?
|
Forecasting | 5 | 2021 | 2951 | 0.250 |
Why?
|
Pregnancy Outcome | 3 | 2019 | 2795 | 0.250 |
Why?
|
Amino Acid Sequence | 7 | 2018 | 13814 | 0.250 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 2 | 2017 | 175 | 0.250 |
Why?
|
Genes, Regulator | 2 | 2003 | 378 | 0.240 |
Why?
|
Enzyme Inhibitors | 4 | 2014 | 3799 | 0.240 |
Why?
|
Gene Library | 3 | 2023 | 1074 | 0.240 |
Why?
|
Vibrio | 1 | 2004 | 41 | 0.240 |
Why?
|
New Zealand | 5 | 2018 | 355 | 0.240 |
Why?
|
DNA, Mitochondrial | 1 | 2009 | 817 | 0.240 |
Why?
|
Polyethylene Glycols | 2 | 2020 | 1182 | 0.240 |
Why?
|
Extracellular Matrix | 2 | 2013 | 1741 | 0.240 |
Why?
|
Metabolomics | 3 | 2017 | 1485 | 0.240 |
Why?
|
Genes, Reporter | 5 | 2020 | 1547 | 0.240 |
Why?
|
Movement | 4 | 2019 | 1471 | 0.240 |
Why?
|
Ligands | 4 | 2022 | 3282 | 0.240 |
Why?
|
Folic Acid Antagonists | 1 | 2024 | 84 | 0.240 |
Why?
|
Polyhydroxyalkanoates | 1 | 2023 | 11 | 0.230 |
Why?
|
Locomotion | 2 | 1999 | 378 | 0.230 |
Why?
|
Knee Joint | 7 | 2002 | 1680 | 0.230 |
Why?
|
Endonucleases | 2 | 2018 | 380 | 0.230 |
Why?
|
Incidence | 19 | 2020 | 20952 | 0.230 |
Why?
|
Registries | 5 | 2014 | 8091 | 0.230 |
Why?
|
Muscle Relaxation | 1 | 2003 | 142 | 0.230 |
Why?
|
Risk Management | 1 | 2007 | 571 | 0.230 |
Why?
|
Nanotechnology | 2 | 2020 | 710 | 0.220 |
Why?
|
Oxidants | 2 | 2014 | 164 | 0.220 |
Why?
|
Cat Diseases | 1 | 2022 | 37 | 0.220 |
Why?
|
Gene Deletion | 4 | 2019 | 2751 | 0.220 |
Why?
|
Microfluidics | 2 | 2023 | 662 | 0.220 |
Why?
|
Shoes | 1 | 2003 | 97 | 0.220 |
Why?
|
Water Pollutants, Chemical | 2 | 2020 | 311 | 0.220 |
Why?
|
Mitral Valve Insufficiency | 8 | 1998 | 1421 | 0.220 |
Why?
|
Peptide Biosynthesis, Nucleic Acid-Independent | 1 | 2022 | 7 | 0.220 |
Why?
|
Middle Aged | 81 | 2020 | 213390 | 0.220 |
Why?
|
Glucose | 1 | 2015 | 4398 | 0.220 |
Why?
|
Periodicity | 3 | 2002 | 364 | 0.220 |
Why?
|
Somatosensory Disorders | 1 | 2002 | 47 | 0.220 |
Why?
|
Trans-Activators | 4 | 2016 | 2926 | 0.210 |
Why?
|
Aerobiosis | 2 | 2013 | 106 | 0.210 |
Why?
|
Models, Statistical | 7 | 2021 | 5101 | 0.210 |
Why?
|
Anthozoa | 1 | 2023 | 62 | 0.210 |
Why?
|
Herbicides | 3 | 2011 | 100 | 0.210 |
Why?
|
Adenine | 2 | 2019 | 936 | 0.210 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 871 | 0.210 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2005 | 442 | 0.210 |
Why?
|
Ligaments, Articular | 3 | 1995 | 299 | 0.210 |
Why?
|
Dog Diseases | 1 | 2022 | 138 | 0.210 |
Why?
|
Rec A Recombinases | 3 | 2012 | 51 | 0.210 |
Why?
|
Mitral Valve Prolapse | 2 | 1994 | 231 | 0.210 |
Why?
|
Genes | 2 | 2003 | 1893 | 0.200 |
Why?
|
Tryptamines | 1 | 2022 | 88 | 0.200 |
Why?
|
Foot | 5 | 2003 | 527 | 0.200 |
Why?
|
Chikungunya virus | 1 | 2022 | 50 | 0.200 |
Why?
|
Cell Lineage | 7 | 2019 | 2504 | 0.200 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 2649 | 0.200 |
Why?
|
Viral Regulatory and Accessory Proteins | 4 | 2005 | 159 | 0.200 |
Why?
|
Aged | 66 | 2017 | 163288 | 0.200 |
Why?
|
Adenosine Triphosphate | 3 | 2015 | 2027 | 0.200 |
Why?
|
Textiles | 1 | 2021 | 46 | 0.200 |
Why?
|
Carbenicillin | 1 | 2021 | 15 | 0.200 |
Why?
|
Genes, Fungal | 1 | 2003 | 455 | 0.200 |
Why?
|
Mice, Inbred C57BL | 10 | 2020 | 21833 | 0.200 |
Why?
|
Liver Neoplasms | 3 | 2014 | 4253 | 0.200 |
Why?
|
K562 Cells | 2 | 2020 | 635 | 0.200 |
Why?
|
Hypesthesia | 1 | 2002 | 109 | 0.200 |
Why?
|
Ketoglutarate Dehydrogenase Complex | 1 | 2021 | 20 | 0.200 |
Why?
|
Streptomycin | 1 | 2021 | 69 | 0.200 |
Why?
|
Musculoskeletal System | 1 | 2003 | 175 | 0.200 |
Why?
|
Bioprosthesis | 6 | 1998 | 597 | 0.200 |
Why?
|
Cohort Studies | 26 | 2018 | 40559 | 0.200 |
Why?
|
Linear Models | 5 | 2018 | 5953 | 0.200 |
Why?
|
Infant, Premature | 1 | 2011 | 2045 | 0.200 |
Why?
|
Electricity | 1 | 2002 | 182 | 0.190 |
Why?
|
Tumor Virus Infections | 3 | 2020 | 454 | 0.190 |
Why?
|
Sarcoma | 6 | 2018 | 1897 | 0.190 |
Why?
|
Premature Birth | 2 | 2011 | 1721 | 0.190 |
Why?
|
Drug Synergism | 3 | 2021 | 1794 | 0.190 |
Why?
|
Equipment and Supplies | 1 | 2003 | 281 | 0.190 |
Why?
|
Teratogens | 1 | 2001 | 112 | 0.190 |
Why?
|
Ribosomes | 1 | 2004 | 500 | 0.190 |
Why?
|
Adenosine Deaminase | 1 | 2023 | 241 | 0.190 |
Why?
|
Pseudomonas fluorescens | 1 | 2020 | 21 | 0.190 |
Why?
|
Mathematics | 7 | 2003 | 728 | 0.190 |
Why?
|
Phylogeny | 3 | 2018 | 2804 | 0.190 |
Why?
|
Dystrophin | 1 | 2022 | 285 | 0.190 |
Why?
|
Regression Analysis | 8 | 2011 | 6459 | 0.190 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2002 | 162 | 0.190 |
Why?
|
Teaching | 2 | 2018 | 1174 | 0.190 |
Why?
|
Microscopy, Atomic Force | 1 | 2021 | 250 | 0.190 |
Why?
|
Nonlinear Dynamics | 6 | 2013 | 502 | 0.180 |
Why?
|
Phalloidine | 1 | 2020 | 21 | 0.180 |
Why?
|
Cercaria | 1 | 2019 | 1 | 0.180 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1400 | 0.180 |
Why?
|
Rotifera | 1 | 2019 | 5 | 0.180 |
Why?
|
Sensation | 1 | 2002 | 336 | 0.180 |
Why?
|
beta-Lactamases | 1 | 2022 | 306 | 0.180 |
Why?
|
Aged, 80 and over | 35 | 2014 | 57776 | 0.180 |
Why?
|
Chemokine CXCL9 | 1 | 2020 | 132 | 0.180 |
Why?
|
Environmental Illness | 1 | 2000 | 34 | 0.180 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.180 |
Why?
|
Labor, Obstetric | 1 | 2023 | 333 | 0.180 |
Why?
|
Membrane Proteins | 4 | 2017 | 7882 | 0.180 |
Why?
|
Sequence Deletion | 2 | 2022 | 1525 | 0.180 |
Why?
|
Neurons | 7 | 2015 | 9340 | 0.180 |
Why?
|
Adolescent | 36 | 2017 | 85779 | 0.180 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4805 | 0.180 |
Why?
|
Parthenogenesis | 1 | 2019 | 31 | 0.170 |
Why?
|
Bacterial Capsules | 1 | 2020 | 251 | 0.170 |
Why?
|
Microbiological Techniques | 1 | 2020 | 102 | 0.170 |
Why?
|
Nerve Net | 5 | 2003 | 2175 | 0.170 |
Why?
|
Cell Division | 3 | 2014 | 4569 | 0.170 |
Why?
|
Electric Stimulation | 5 | 2003 | 1767 | 0.170 |
Why?
|
Occupational Medicine | 1 | 2000 | 115 | 0.170 |
Why?
|
Bone Marrow | 2 | 2024 | 2948 | 0.170 |
Why?
|
DNA Cleavage | 1 | 2019 | 58 | 0.170 |
Why?
|
Mechanoreceptors | 2 | 2001 | 186 | 0.170 |
Why?
|
Temperature | 6 | 2023 | 2204 | 0.170 |
Why?
|
Polyomavirus | 1 | 2020 | 249 | 0.170 |
Why?
|
Atlases as Topic | 1 | 2020 | 236 | 0.170 |
Why?
|
Haploidy | 1 | 2019 | 136 | 0.170 |
Why?
|
Solvents | 2 | 1997 | 302 | 0.170 |
Why?
|
Models, Neurological | 2 | 1999 | 1775 | 0.170 |
Why?
|
Muscular Diseases | 2 | 2013 | 555 | 0.170 |
Why?
|
Kinetics | 4 | 2020 | 6476 | 0.170 |
Why?
|
Protein Binding | 4 | 2022 | 9384 | 0.170 |
Why?
|
Thermodynamics | 1 | 2020 | 594 | 0.170 |
Why?
|
Fluoroquinolones | 1 | 2021 | 310 | 0.170 |
Why?
|
Transgenes | 2 | 2022 | 1009 | 0.170 |
Why?
|
Recombinant Fusion Proteins | 4 | 2021 | 3773 | 0.160 |
Why?
|
Colic | 1 | 2018 | 42 | 0.160 |
Why?
|
Statistics as Topic | 5 | 2002 | 2373 | 0.160 |
Why?
|
HEK293 Cells | 6 | 2021 | 4208 | 0.160 |
Why?
|
TATA Box | 2 | 2010 | 128 | 0.160 |
Why?
|
Information Dissemination | 1 | 2007 | 1099 | 0.160 |
Why?
|
Accidental Falls | 5 | 2014 | 1062 | 0.160 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2001 | 317 | 0.160 |
Why?
|
Alkaloids | 1 | 2019 | 190 | 0.160 |
Why?
|
Forced Expiratory Volume | 3 | 2017 | 1745 | 0.160 |
Why?
|
Microbial Consortia | 1 | 2018 | 32 | 0.160 |
Why?
|
Oxidative Phosphorylation | 2 | 2017 | 481 | 0.160 |
Why?
|
Dengue Virus | 2 | 2018 | 204 | 0.160 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2018 | 88 | 0.160 |
Why?
|
Muscle Strength | 2 | 2020 | 592 | 0.160 |
Why?
|
Ovum | 1 | 2019 | 189 | 0.160 |
Why?
|
Follow-Up Studies | 23 | 2013 | 39052 | 0.160 |
Why?
|
Palliative Care | 4 | 1998 | 3493 | 0.160 |
Why?
|
Alternative Splicing | 2 | 2014 | 1117 | 0.160 |
Why?
|
Parkinson Disease | 4 | 2014 | 2775 | 0.160 |
Why?
|
Arabinose | 2 | 2009 | 31 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2018 | 2839 | 0.160 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2018 | 954 | 0.160 |
Why?
|
Sulfhydryl Compounds | 1 | 1999 | 298 | 0.160 |
Why?
|
Home Nursing | 1 | 1998 | 92 | 0.160 |
Why?
|
Gastrointestinal Tract | 2 | 2014 | 814 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.160 |
Why?
|
Codon, Terminator | 1 | 2018 | 127 | 0.160 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 200 | 0.150 |
Why?
|
Paneth Cells | 1 | 2018 | 99 | 0.150 |
Why?
|
2,4-Dichlorophenoxyacetic Acid | 2 | 2011 | 21 | 0.150 |
Why?
|
Analgesics, Opioid | 4 | 1999 | 3677 | 0.150 |
Why?
|
Spinal Cord | 2 | 1999 | 1810 | 0.150 |
Why?
|
Dextrans | 1 | 2020 | 595 | 0.150 |
Why?
|
Growth Substances | 1 | 2020 | 784 | 0.150 |
Why?
|
DNA, Single-Stranded | 1 | 2019 | 355 | 0.150 |
Why?
|
Tuberous Sclerosis | 1 | 2006 | 1029 | 0.150 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 720 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1060 | 0.150 |
Why?
|
Population Dynamics | 1 | 2019 | 302 | 0.150 |
Why?
|
DNA, Superhelical | 1 | 2017 | 50 | 0.150 |
Why?
|
Energy Metabolism | 2 | 2021 | 2897 | 0.150 |
Why?
|
Nanoparticles | 3 | 2020 | 1905 | 0.150 |
Why?
|
Cells, Cultured | 13 | 2023 | 19233 | 0.150 |
Why?
|
Sexual Maturation | 1 | 2019 | 265 | 0.150 |
Why?
|
Fluconazole | 1 | 2017 | 146 | 0.150 |
Why?
|
Carcinogens, Environmental | 1 | 1997 | 67 | 0.150 |
Why?
|
Permeability | 1 | 2019 | 738 | 0.150 |
Why?
|
Guidelines as Topic | 3 | 2019 | 1405 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 2 | 2020 | 1832 | 0.150 |
Why?
|
Euthanasia | 1 | 1997 | 51 | 0.150 |
Why?
|
Leg | 2 | 1995 | 1116 | 0.150 |
Why?
|
Quorum Sensing | 1 | 2018 | 131 | 0.150 |
Why?
|
Immune Evasion | 1 | 2020 | 360 | 0.150 |
Why?
|
Antimalarials | 1 | 2024 | 905 | 0.150 |
Why?
|
Enzyme Assays | 1 | 2018 | 111 | 0.150 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1903 | 0.150 |
Why?
|
Child | 30 | 2020 | 77709 | 0.150 |
Why?
|
Leukemia, Experimental | 3 | 1983 | 246 | 0.150 |
Why?
|
RNA, Antisense | 1 | 2017 | 138 | 0.150 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 687 | 0.150 |
Why?
|
Genes, Lethal | 1 | 2017 | 242 | 0.150 |
Why?
|
Cloning, Molecular | 2 | 2020 | 4320 | 0.140 |
Why?
|
Obstetric Labor Complications | 1 | 2019 | 238 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 4 | 2020 | 2505 | 0.140 |
Why?
|
DNA, Fungal | 1 | 2018 | 280 | 0.140 |
Why?
|
Aortic Aneurysm | 4 | 1997 | 644 | 0.140 |
Why?
|
Terminal Care | 4 | 1997 | 1694 | 0.140 |
Why?
|
Protein Processing, Post-Translational | 1 | 2005 | 1988 | 0.140 |
Why?
|
Arthrogryposis | 1 | 2017 | 72 | 0.140 |
Why?
|
Plants | 2 | 2015 | 316 | 0.140 |
Why?
|
DNA Replication | 3 | 2014 | 1399 | 0.140 |
Why?
|
Stomach Ulcer | 1 | 2016 | 125 | 0.140 |
Why?
|
CCAAT-Binding Factor | 1 | 2016 | 23 | 0.140 |
Why?
|
Fishes | 1 | 1999 | 569 | 0.140 |
Why?
|
Hydromorphone | 1 | 1996 | 65 | 0.140 |
Why?
|
Spermatogonia | 1 | 2016 | 29 | 0.140 |
Why?
|
Antigens, Helminth | 1 | 2016 | 64 | 0.140 |
Why?
|
Immunoassay | 1 | 2020 | 752 | 0.140 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2010 | 286 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2021 | 587 | 0.140 |
Why?
|
Clavulanic Acids | 4 | 1996 | 11 | 0.140 |
Why?
|
Ribonucleases | 1 | 2017 | 287 | 0.140 |
Why?
|
Analgesia, Patient-Controlled | 1 | 1996 | 109 | 0.140 |
Why?
|
Cyclins | 1 | 1998 | 603 | 0.140 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2016 | 129 | 0.140 |
Why?
|
Myography | 1 | 2017 | 109 | 0.140 |
Why?
|
RNA, Helminth | 1 | 2016 | 59 | 0.140 |
Why?
|
Pregnancy Complications | 2 | 2019 | 2861 | 0.140 |
Why?
|
Cross-Linking Reagents | 1 | 2019 | 694 | 0.140 |
Why?
|
Fentanyl | 1 | 1999 | 409 | 0.140 |
Why?
|
High-Throughput Screening Assays | 2 | 2023 | 944 | 0.140 |
Why?
|
Flow Cytometry | 5 | 2019 | 5974 | 0.140 |
Why?
|
Blood Vessel Prosthesis | 4 | 1996 | 934 | 0.140 |
Why?
|
Peristalsis | 1 | 2015 | 60 | 0.140 |
Why?
|
Receptors, Erythropoietin | 1 | 2016 | 147 | 0.140 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 4 | 1996 | 30 | 0.140 |
Why?
|
Cell Death | 2 | 2014 | 1707 | 0.130 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2014 | 520 | 0.130 |
Why?
|
5-Hydroxytryptophan | 1 | 2015 | 32 | 0.130 |
Why?
|
Purines | 1 | 2019 | 594 | 0.130 |
Why?
|
Skin | 4 | 2023 | 4372 | 0.130 |
Why?
|
Texas | 2 | 2008 | 391 | 0.130 |
Why?
|
Ascorbic Acid | 1 | 2019 | 651 | 0.130 |
Why?
|
Embryo, Nonmammalian | 1 | 2019 | 895 | 0.130 |
Why?
|
Environmental Monitoring | 5 | 2017 | 1414 | 0.130 |
Why?
|
Longevity | 3 | 2008 | 1071 | 0.130 |
Why?
|
Sequence Alignment | 2 | 2010 | 2256 | 0.130 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 22 | 0.130 |
Why?
|
Bronchitis | 2 | 1995 | 200 | 0.130 |
Why?
|
Research | 3 | 2014 | 1999 | 0.130 |
Why?
|
Skin Physiological Phenomena | 1 | 1996 | 180 | 0.130 |
Why?
|
Cytomegalovirus | 1 | 2020 | 733 | 0.130 |
Why?
|
Malaria, Falciparum | 1 | 2024 | 1077 | 0.130 |
Why?
|
Motor Skills | 1 | 1998 | 522 | 0.130 |
Why?
|
Hypogravity | 1 | 1995 | 3 | 0.130 |
Why?
|
Body Height | 2 | 2020 | 1578 | 0.130 |
Why?
|
Nucleic Acid Conformation | 2 | 2019 | 913 | 0.130 |
Why?
|
Entomoplasmataceae | 1 | 2014 | 1 | 0.130 |
Why?
|
Fluorescent Dyes | 3 | 2015 | 1917 | 0.130 |
Why?
|
Amitriptyline | 1 | 1995 | 110 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2014 | 8432 | 0.130 |
Why?
|
Periaqueductal Gray | 1 | 1995 | 108 | 0.130 |
Why?
|
Plectin | 1 | 2014 | 14 | 0.130 |
Why?
|
Spermatogenesis | 1 | 2016 | 262 | 0.130 |
Why?
|
Confidence Intervals | 8 | 2010 | 2971 | 0.130 |
Why?
|
DNA, Viral | 2 | 2020 | 2227 | 0.130 |
Why?
|
Epidermolysis Bullosa Simplex | 1 | 2014 | 13 | 0.130 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2008 | 852 | 0.130 |
Why?
|
Aortic Valve | 13 | 1998 | 1924 | 0.130 |
Why?
|
Survival Rate | 16 | 2008 | 12788 | 0.130 |
Why?
|
Soft Tissue Neoplasms | 4 | 2009 | 1363 | 0.130 |
Why?
|
Alcohol Dehydrogenase | 1 | 1995 | 119 | 0.130 |
Why?
|
Epidermis | 1 | 2018 | 528 | 0.130 |
Why?
|
Rats | 15 | 2022 | 24252 | 0.130 |
Why?
|
Oncogene Proteins | 2 | 2016 | 749 | 0.120 |
Why?
|
Green Chemistry Technology | 1 | 2014 | 9 | 0.120 |
Why?
|
Zebrafish | 3 | 2022 | 2996 | 0.120 |
Why?
|
Amoxicillin | 4 | 1996 | 170 | 0.120 |
Why?
|
Lymphopenia | 1 | 1997 | 285 | 0.120 |
Why?
|
Psychomotor Performance | 1 | 2003 | 1901 | 0.120 |
Why?
|
Peer Group | 1 | 2019 | 635 | 0.120 |
Why?
|
Amino Acids, Essential | 1 | 2014 | 24 | 0.120 |
Why?
|
Sequence Analysis, RNA | 3 | 2018 | 2012 | 0.120 |
Why?
|
Joints | 2 | 2000 | 327 | 0.120 |
Why?
|
Collagen Type XII | 1 | 2013 | 3 | 0.120 |
Why?
|
Biomedical Research | 2 | 2021 | 3309 | 0.120 |
Why?
|
Otitis Media with Effusion | 1 | 1995 | 114 | 0.120 |
Why?
|
Host Factor 1 Protein | 1 | 2014 | 15 | 0.120 |
Why?
|
Theophylline | 3 | 1988 | 132 | 0.120 |
Why?
|
Public Health | 2 | 2023 | 2602 | 0.120 |
Why?
|
Substrate Specificity | 2 | 2023 | 1802 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 1312 | 0.120 |
Why?
|
RGS Proteins | 1 | 2014 | 77 | 0.120 |
Why?
|
Hematopoiesis | 3 | 2024 | 2073 | 0.120 |
Why?
|
Fibroblasts | 5 | 2023 | 4162 | 0.120 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2016 | 504 | 0.120 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2014 | 90 | 0.120 |
Why?
|
Death Certificates | 1 | 2014 | 169 | 0.120 |
Why?
|
Risk Factors | 23 | 2019 | 72296 | 0.120 |
Why?
|
Proviruses | 1 | 2015 | 318 | 0.120 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2014 | 90 | 0.120 |
Why?
|
Nurses | 1 | 2003 | 2462 | 0.120 |
Why?
|
United States Occupational Safety and Health Administration | 2 | 2023 | 56 | 0.120 |
Why?
|
Perceptual Masking | 2 | 2006 | 94 | 0.120 |
Why?
|
Age Factors | 14 | 2017 | 18373 | 0.120 |
Why?
|
Metalloproteins | 1 | 2014 | 100 | 0.120 |
Why?
|
Risk Assessment | 11 | 2019 | 23336 | 0.120 |
Why?
|
Mice, Inbred BALB C | 3 | 2020 | 6386 | 0.120 |
Why?
|
Mesencephalon | 1 | 1995 | 329 | 0.120 |
Why?
|
West Virginia | 2 | 2006 | 28 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.110 |
Why?
|
Miconazole | 1 | 2013 | 7 | 0.110 |
Why?
|
Rhabdoid Tumor | 1 | 1995 | 212 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 808 | 0.110 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2015 | 594 | 0.110 |
Why?
|
Otitis Media | 1 | 1996 | 277 | 0.110 |
Why?
|
Cell Line | 5 | 2020 | 16000 | 0.110 |
Why?
|
Weight Lifting | 1 | 1994 | 131 | 0.110 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 820 | 0.110 |
Why?
|
Praziquantel | 2 | 2023 | 25 | 0.110 |
Why?
|
Allergens | 1 | 2020 | 1320 | 0.110 |
Why?
|
Epidemiologic Methods | 5 | 2007 | 1364 | 0.110 |
Why?
|
Host Specificity | 1 | 2013 | 53 | 0.110 |
Why?
|
Environment | 2 | 2017 | 1123 | 0.110 |
Why?
|
Iron | 3 | 2013 | 1774 | 0.110 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 695 | 0.110 |
Why?
|
Severity of Illness Index | 7 | 2017 | 15535 | 0.110 |
Why?
|
Body Mass Index | 4 | 2017 | 12721 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 695 | 0.110 |
Why?
|
Ureaplasma Infections | 1 | 2012 | 24 | 0.110 |
Why?
|
Physical Stimulation | 3 | 2003 | 525 | 0.110 |
Why?
|
Ureaplasma | 1 | 2012 | 59 | 0.110 |
Why?
|
Seizures | 1 | 2006 | 2859 | 0.110 |
Why?
|
Electric Impedance | 1 | 2017 | 729 | 0.110 |
Why?
|
Mucous Membrane | 1 | 1996 | 673 | 0.110 |
Why?
|
Helminthiasis | 1 | 2013 | 66 | 0.110 |
Why?
|
Maternal Exposure | 2 | 2011 | 961 | 0.110 |
Why?
|
Anesthesia, Conduction | 1 | 1996 | 238 | 0.110 |
Why?
|
Postoperative Complications | 19 | 2020 | 15297 | 0.110 |
Why?
|
Bronchial Hyperreactivity | 1 | 1994 | 319 | 0.110 |
Why?
|
Child, Preschool | 16 | 2018 | 41005 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 1996 | 316 | 0.110 |
Why?
|
Pregnenediones | 1 | 2012 | 29 | 0.110 |
Why?
|
Erythrocytes | 2 | 2019 | 2455 | 0.110 |
Why?
|
Homozygote | 1 | 2017 | 1787 | 0.110 |
Why?
|
Amphotericin B | 1 | 2013 | 137 | 0.110 |
Why?
|
Biomimetics | 1 | 2014 | 172 | 0.110 |
Why?
|
Prostatic Neoplasms | 4 | 2007 | 11126 | 0.110 |
Why?
|
Antioxidants | 2 | 2014 | 1659 | 0.110 |
Why?
|
Communication | 2 | 2018 | 3750 | 0.110 |
Why?
|
Sensory Thresholds | 3 | 2002 | 391 | 0.110 |
Why?
|
Muscles | 3 | 1996 | 1614 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12356 | 0.110 |
Why?
|
Immunization, Passive | 5 | 1983 | 623 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2020 | 1041 | 0.110 |
Why?
|
Retrospective Studies | 22 | 2019 | 77460 | 0.110 |
Why?
|
Space Flight | 1 | 1995 | 188 | 0.110 |
Why?
|
Guanine Nucleotides | 1 | 2012 | 68 | 0.110 |
Why?
|
Multipotent Stem Cells | 1 | 2013 | 186 | 0.110 |
Why?
|
Coronary Disease | 7 | 1995 | 6077 | 0.110 |
Why?
|
Endopeptidase Clp | 1 | 2012 | 47 | 0.110 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2013 | 185 | 0.110 |
Why?
|
Muscle Contraction | 2 | 1995 | 1235 | 0.100 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6621 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2019 | 10943 | 0.100 |
Why?
|
Recovery of Function | 1 | 2002 | 2926 | 0.100 |
Why?
|
Organoids | 1 | 2018 | 701 | 0.100 |
Why?
|
Electron Transport | 1 | 2013 | 211 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1994 | 798 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1271 | 0.100 |
Why?
|
Bacterial Toxins | 2 | 2015 | 931 | 0.100 |
Why?
|
DNA Restriction Enzymes | 1 | 2012 | 570 | 0.100 |
Why?
|
Databases, Factual | 4 | 2019 | 7730 | 0.100 |
Why?
|
Disorders of Sex Development | 1 | 2013 | 122 | 0.100 |
Why?
|
Phagocytosis | 1 | 2017 | 1539 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 2016 | 0.100 |
Why?
|
Adhesins, Bacterial | 1 | 2012 | 119 | 0.100 |
Why?
|
Genes, Viral | 1 | 2013 | 718 | 0.100 |
Why?
|
Erythropoiesis | 3 | 2024 | 706 | 0.100 |
Why?
|
DNA Fragmentation | 1 | 2012 | 242 | 0.100 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 851 | 0.100 |
Why?
|
Administration, Inhalation | 4 | 2008 | 1105 | 0.100 |
Why?
|
Ebolavirus | 1 | 2014 | 263 | 0.100 |
Why?
|
Motor Neurons | 2 | 1999 | 844 | 0.100 |
Why?
|
Gene Amplification | 1 | 2016 | 1063 | 0.100 |
Why?
|
Genetic Code | 1 | 2012 | 154 | 0.100 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2011 | 24 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8385 | 0.100 |
Why?
|
beta-Lactams | 1 | 2013 | 160 | 0.100 |
Why?
|
Proton-Motive Force | 1 | 2011 | 7 | 0.100 |
Why?
|
Ultrasonic Therapy | 1 | 1994 | 235 | 0.100 |
Why?
|
Upper Extremity | 1 | 2016 | 648 | 0.100 |
Why?
|
Lymphocyte Activation | 4 | 2018 | 5524 | 0.100 |
Why?
|
Odds Ratio | 6 | 2017 | 9849 | 0.100 |
Why?
|
Automation | 1 | 2014 | 584 | 0.100 |
Why?
|
Soil Pollutants | 1 | 2012 | 71 | 0.100 |
Why?
|
DNA, Helminth | 1 | 2011 | 34 | 0.100 |
Why?
|
Testis | 2 | 2014 | 804 | 0.100 |
Why?
|
Erythropoietin | 1 | 2016 | 726 | 0.100 |
Why?
|
Heart Valves | 1 | 1993 | 291 | 0.100 |
Why?
|
Chorioamnionitis | 1 | 2012 | 155 | 0.100 |
Why?
|
Animal Structures | 1 | 2011 | 23 | 0.100 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2703 | 0.100 |
Why?
|
Melanoma | 3 | 2021 | 5511 | 0.100 |
Why?
|
Biological Clocks | 1 | 1994 | 322 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.100 |
Why?
|
Antigens, Viral | 4 | 1978 | 1035 | 0.100 |
Why?
|
Biological Products | 1 | 2020 | 860 | 0.100 |
Why?
|
Disulfides | 1 | 2013 | 457 | 0.100 |
Why?
|
Culicidae | 1 | 2011 | 105 | 0.100 |
Why?
|
Central Nervous System | 1 | 1998 | 1357 | 0.100 |
Why?
|
Anabolic Agents | 1 | 2013 | 247 | 0.100 |
Why?
|
Reproducibility of Results | 8 | 2014 | 19905 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3464 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3505 | 0.100 |
Why?
|
Friend murine leukemia virus | 5 | 1983 | 65 | 0.100 |
Why?
|
Birth Certificates | 1 | 2011 | 67 | 0.100 |
Why?
|
North America | 1 | 2014 | 1249 | 0.100 |
Why?
|
Chromosomes, Bacterial | 1 | 2012 | 282 | 0.100 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2400 | 0.100 |
Why?
|
Phosphatidylserines | 1 | 2012 | 193 | 0.100 |
Why?
|
Eye | 1 | 2015 | 729 | 0.100 |
Why?
|
Guanine | 1 | 2012 | 274 | 0.100 |
Why?
|
Safety Management | 2 | 2007 | 783 | 0.090 |
Why?
|
Insect Vectors | 1 | 2011 | 134 | 0.090 |
Why?
|
Bioreactors | 1 | 2012 | 236 | 0.090 |
Why?
|
Electromyography | 4 | 2003 | 1379 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1095 | 0.090 |
Why?
|
Homeostasis | 1 | 2022 | 3339 | 0.090 |
Why?
|
Genes, Recessive | 1 | 2013 | 641 | 0.090 |
Why?
|
Peptide Elongation Factors | 1 | 2010 | 62 | 0.090 |
Why?
|
Serotonin | 1 | 2015 | 1017 | 0.090 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 491 | 0.090 |
Why?
|
Acrylamide | 2 | 2007 | 60 | 0.090 |
Why?
|
Trimethadione | 2 | 2008 | 2 | 0.090 |
Why?
|
Rifamycins | 1 | 2010 | 25 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 1996 | 639 | 0.090 |
Why?
|
Erythrocyte Indices | 1 | 1991 | 146 | 0.090 |
Why?
|
Platelet Aggregation | 2 | 2012 | 798 | 0.090 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 2010 | 371 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 3 | 1999 | 2249 | 0.090 |
Why?
|
Analgesia | 1 | 1995 | 461 | 0.090 |
Why?
|
Hyperthermia, Induced | 1 | 1994 | 403 | 0.090 |
Why?
|
Dystroglycans | 1 | 2010 | 60 | 0.090 |
Why?
|
Cell Cycle | 1 | 1998 | 2967 | 0.090 |
Why?
|
Nuclear Proteins | 2 | 2016 | 5856 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13693 | 0.090 |
Why?
|
Biofuels | 1 | 2010 | 41 | 0.090 |
Why?
|
Blood Cell Count | 1 | 1991 | 403 | 0.090 |
Why?
|
Octamer Transcription Factor-3 | 3 | 2017 | 223 | 0.090 |
Why?
|
Reoperation | 13 | 1997 | 4201 | 0.090 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 112 | 0.090 |
Why?
|
Inflammation | 3 | 2018 | 10637 | 0.090 |
Why?
|
Chronic Disease | 1 | 2005 | 9145 | 0.090 |
Why?
|
Nerve Regeneration | 1 | 2016 | 788 | 0.090 |
Why?
|
Neuropeptides | 1 | 2016 | 942 | 0.090 |
Why?
|
Pregnancy | 9 | 2023 | 29144 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2016 | 3524 | 0.090 |
Why?
|
Genetic Testing | 2 | 2020 | 3444 | 0.090 |
Why?
|
Cholesterol | 1 | 2019 | 2919 | 0.090 |
Why?
|
Pain | 4 | 2000 | 4988 | 0.090 |
Why?
|
Technology, Pharmaceutical | 1 | 2010 | 84 | 0.090 |
Why?
|
Ovary | 1 | 2014 | 981 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1837 | 0.090 |
Why?
|
Flocculation | 1 | 2009 | 3 | 0.090 |
Why?
|
Bioelectric Energy Sources | 1 | 2009 | 17 | 0.090 |
Why?
|
Integrin alpha Chains | 1 | 2010 | 97 | 0.090 |
Why?
|
Macaca mulatta | 1 | 2016 | 2377 | 0.090 |
Why?
|
Infant | 11 | 2018 | 35134 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 647 | 0.090 |
Why?
|
Head | 1 | 2015 | 880 | 0.090 |
Why?
|
Scotoma | 1 | 1990 | 139 | 0.090 |
Why?
|
Treatment Outcome | 16 | 2020 | 63107 | 0.090 |
Why?
|
Cell Transplantation | 1 | 2011 | 477 | 0.090 |
Why?
|
Survival Analysis | 10 | 2009 | 10252 | 0.090 |
Why?
|
Fingers | 2 | 2003 | 513 | 0.090 |
Why?
|
Neurosurgery | 1 | 1996 | 643 | 0.090 |
Why?
|
Methylmethacrylates | 1 | 1989 | 72 | 0.080 |
Why?
|
HeLa Cells | 1 | 2015 | 3130 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2012 | 539 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.080 |
Why?
|
Amino Acids | 2 | 2014 | 1737 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1480 | 0.080 |
Why?
|
Caspases | 1 | 2012 | 928 | 0.080 |
Why?
|
Light | 1 | 2015 | 1374 | 0.080 |
Why?
|
Cross-Sectional Studies | 9 | 2017 | 25039 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2020 | 2148 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2012 | 1263 | 0.080 |
Why?
|
Hematologic Tests | 1 | 2010 | 240 | 0.080 |
Why?
|
Myocardial Ischemia | 2 | 2016 | 2148 | 0.080 |
Why?
|
Infant, Newborn | 7 | 2018 | 25628 | 0.080 |
Why?
|
Manufactured Materials | 1 | 2008 | 19 | 0.080 |
Why?
|
Sequence Analysis, Protein | 1 | 2010 | 258 | 0.080 |
Why?
|
Antigens, CD34 | 3 | 2019 | 659 | 0.080 |
Why?
|
Urinary Tract Infections | 2 | 2011 | 788 | 0.080 |
Why?
|
Protein Denaturation | 1 | 2008 | 237 | 0.080 |
Why?
|
Fibronectins | 1 | 2012 | 726 | 0.080 |
Why?
|
Sodium | 1 | 2014 | 1622 | 0.080 |
Why?
|
Colony Count, Microbial | 2 | 2007 | 331 | 0.080 |
Why?
|
Drug Resistance | 3 | 2022 | 1608 | 0.080 |
Why?
|
Analgesics | 1 | 1995 | 1040 | 0.080 |
Why?
|
Neuroblastoma | 1 | 2016 | 1226 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.080 |
Why?
|
Selenoproteins | 1 | 2010 | 216 | 0.080 |
Why?
|
Dyneins | 1 | 2008 | 123 | 0.080 |
Why?
|
Pyridones | 1 | 2013 | 711 | 0.080 |
Why?
|
2,2'-Dipyridyl | 1 | 2007 | 11 | 0.080 |
Why?
|
Carbon-Sulfur Lyases | 1 | 2007 | 11 | 0.080 |
Why?
|
Glucocorticoids | 2 | 2020 | 2108 | 0.080 |
Why?
|
Young Adult | 9 | 2019 | 56429 | 0.080 |
Why?
|
Pulmonary Edema | 1 | 2011 | 414 | 0.080 |
Why?
|
Tissue Donors | 1 | 2017 | 2241 | 0.080 |
Why?
|
Regenerative Medicine | 1 | 2011 | 307 | 0.080 |
Why?
|
Stroke | 3 | 2006 | 9981 | 0.080 |
Why?
|
Simian virus 40 | 3 | 1973 | 297 | 0.080 |
Why?
|
Actuarial Analysis | 5 | 1998 | 378 | 0.080 |
Why?
|
Ferrous Compounds | 1 | 2007 | 42 | 0.080 |
Why?
|
Kidney | 3 | 2020 | 7184 | 0.080 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 468 | 0.080 |
Why?
|
Antibodies, Viral | 5 | 2022 | 3177 | 0.080 |
Why?
|
HIV-1 | 1 | 2005 | 6939 | 0.080 |
Why?
|
Acrylamides | 1 | 1989 | 255 | 0.080 |
Why?
|
Homeodomain Proteins | 2 | 2014 | 2418 | 0.080 |
Why?
|
Leukemia Virus, Murine | 2 | 1978 | 117 | 0.080 |
Why?
|
Keratinocytes | 1 | 2011 | 799 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1060 | 0.080 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2716 | 0.080 |
Why?
|
Actins | 1 | 2015 | 2121 | 0.080 |
Why?
|
Planning Techniques | 2 | 2000 | 82 | 0.070 |
Why?
|
Evolution, Molecular | 2 | 2014 | 1939 | 0.070 |
Why?
|
Growth Disorders | 1 | 2012 | 645 | 0.070 |
Why?
|
Smoking | 6 | 2010 | 8987 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2014 | 828 | 0.070 |
Why?
|
Metabolism, Inborn Errors | 1 | 2009 | 288 | 0.070 |
Why?
|
DNA Repair | 2 | 2014 | 2046 | 0.070 |
Why?
|
Intestinal Mucosa | 2 | 2015 | 3037 | 0.070 |
Why?
|
Fertility Agents, Female | 1 | 2007 | 99 | 0.070 |
Why?
|
Human Growth Hormone | 1 | 2012 | 683 | 0.070 |
Why?
|
Exercise Test | 2 | 2014 | 2073 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5749 | 0.070 |
Why?
|
Health Education | 1 | 1994 | 1056 | 0.070 |
Why?
|
Hip Joint | 3 | 2001 | 1002 | 0.070 |
Why?
|
Tocotrienols | 1 | 2006 | 3 | 0.070 |
Why?
|
Cell Wall | 1 | 2010 | 422 | 0.070 |
Why?
|
Interneurons | 1 | 1992 | 577 | 0.070 |
Why?
|
Drug Therapy | 1 | 2010 | 497 | 0.070 |
Why?
|
Drosophila melanogaster | 1 | 2016 | 1708 | 0.070 |
Why?
|
Gestational Age | 2 | 2017 | 3493 | 0.070 |
Why?
|
Nitrogen Fixation | 1 | 1986 | 60 | 0.070 |
Why?
|
Ginkgo biloba | 1 | 2006 | 26 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 4 | 1999 | 3537 | 0.070 |
Why?
|
Intestines | 2 | 2012 | 1924 | 0.070 |
Why?
|
Ethylenediamines | 1 | 2006 | 48 | 0.070 |
Why?
|
Cardiomyopathies | 2 | 2014 | 1912 | 0.070 |
Why?
|
Furans | 1 | 2007 | 194 | 0.070 |
Why?
|
Cell Survival | 4 | 2021 | 5882 | 0.070 |
Why?
|
Isopropyl Thiogalactoside | 1 | 2006 | 12 | 0.070 |
Why?
|
Anemia | 1 | 2016 | 1503 | 0.070 |
Why?
|
Free Radical Scavengers | 1 | 2007 | 216 | 0.070 |
Why?
|
Iron Chelating Agents | 1 | 2007 | 139 | 0.070 |
Why?
|
Diphtheria Toxin | 1 | 2007 | 255 | 0.070 |
Why?
|
Health Status | 1 | 2000 | 4034 | 0.070 |
Why?
|
Body Weight | 6 | 2017 | 4671 | 0.070 |
Why?
|
Blindness | 1 | 1990 | 615 | 0.070 |
Why?
|
Protein Precursors | 1 | 2010 | 1154 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 1996 | 1540 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3864 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 1 | 2007 | 295 | 0.070 |
Why?
|
Cell Biology | 1 | 2007 | 92 | 0.070 |
Why?
|
Salicylates | 1 | 2006 | 126 | 0.070 |
Why?
|
Visual Perception | 1 | 1995 | 1420 | 0.070 |
Why?
|
Job Description | 1 | 2006 | 58 | 0.070 |
Why?
|
Cricetinae | 3 | 2007 | 2475 | 0.070 |
Why?
|
Models, Animal | 2 | 2010 | 2173 | 0.070 |
Why?
|
Collagen | 2 | 2013 | 2688 | 0.070 |
Why?
|
Organizational Policy | 2 | 2007 | 429 | 0.070 |
Why?
|
Nursing Staff | 1 | 2007 | 129 | 0.070 |
Why?
|
Recurrence | 4 | 2015 | 8340 | 0.070 |
Why?
|
Case-Control Studies | 6 | 2018 | 21748 | 0.070 |
Why?
|
Occupations | 1 | 2008 | 517 | 0.070 |
Why?
|
Blood Transfusion | 1 | 1992 | 1301 | 0.070 |
Why?
|
Stilbenes | 1 | 2006 | 155 | 0.070 |
Why?
|
Cricetulus | 1 | 2007 | 818 | 0.070 |
Why?
|
Chemotaxis | 1 | 2008 | 607 | 0.070 |
Why?
|
Treatment Failure | 1 | 2011 | 2618 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 1941 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 16690 | 0.060 |
Why?
|
Prosthesis Design | 4 | 2001 | 2110 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2009 | 3480 | 0.060 |
Why?
|
Prostate | 1 | 2013 | 1775 | 0.060 |
Why?
|
Anorexia | 1 | 2006 | 161 | 0.060 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2005 | 45 | 0.060 |
Why?
|
Drug Administration Schedule | 5 | 1996 | 4933 | 0.060 |
Why?
|
Fetal Blood | 1 | 2011 | 1318 | 0.060 |
Why?
|
Phenols | 1 | 2009 | 497 | 0.060 |
Why?
|
Valproic Acid | 1 | 2008 | 445 | 0.060 |
Why?
|
Protein Folding | 1 | 2008 | 840 | 0.060 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2006 | 361 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1692 | 0.060 |
Why?
|
Ubiquinone | 1 | 2006 | 188 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4251 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 1990 | 935 | 0.060 |
Why?
|
Analysis of Variance | 4 | 2004 | 6366 | 0.060 |
Why?
|
Infant Mortality | 1 | 2010 | 754 | 0.060 |
Why?
|
Integrases | 1 | 2007 | 533 | 0.060 |
Why?
|
Klebsiella pneumoniae | 1 | 1986 | 251 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2021 | 14723 | 0.060 |
Why?
|
Spirometry | 2 | 2017 | 865 | 0.060 |
Why?
|
Vital Capacity | 2 | 2017 | 925 | 0.060 |
Why?
|
Research Design | 3 | 2010 | 5984 | 0.060 |
Why?
|
CHO Cells | 1 | 2007 | 1409 | 0.060 |
Why?
|
Cell Communication | 2 | 2022 | 1621 | 0.060 |
Why?
|
Galactosides | 1 | 2024 | 52 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4463 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2007 | 0.060 |
Why?
|
Diffusion | 2 | 2017 | 832 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10183 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.060 |
Why?
|
Biophysical Phenomena | 3 | 2017 | 327 | 0.060 |
Why?
|
Heart Ventricles | 3 | 2014 | 3817 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2008 | 1472 | 0.060 |
Why?
|
Behavioral Symptoms | 1 | 2006 | 175 | 0.060 |
Why?
|
Epithelium | 1 | 2009 | 1679 | 0.060 |
Why?
|
Nitriles | 1 | 1989 | 955 | 0.060 |
Why?
|
Genetics | 1 | 2004 | 112 | 0.060 |
Why?
|
Publication Bias | 1 | 2004 | 162 | 0.060 |
Why?
|
Autophagy | 1 | 2011 | 1297 | 0.060 |
Why?
|
Hazardous Substances | 1 | 2004 | 149 | 0.060 |
Why?
|
Binding Sites | 2 | 2015 | 6111 | 0.060 |
Why?
|
NAD | 1 | 2007 | 590 | 0.060 |
Why?
|
Animals, Wild | 1 | 2023 | 90 | 0.060 |
Why?
|
Thioredoxins | 1 | 2005 | 213 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2010 | 6171 | 0.060 |
Why?
|
Causality | 2 | 2007 | 1275 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1525 | 0.060 |
Why?
|
Gait Disorders, Neurologic | 1 | 2006 | 231 | 0.060 |
Why?
|
Fenbendazole | 1 | 2022 | 1 | 0.060 |
Why?
|
Pyrantel Pamoate | 1 | 2022 | 1 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 2014 | 4666 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1992 | 1265 | 0.060 |
Why?
|
Administration, Oral | 5 | 2008 | 3914 | 0.060 |
Why?
|
Ancylostomatoidea | 1 | 2022 | 4 | 0.060 |
Why?
|
Muscle Weakness | 2 | 2018 | 413 | 0.060 |
Why?
|
Prenatal Care | 1 | 2011 | 1092 | 0.060 |
Why?
|
Ancylostoma | 1 | 2022 | 10 | 0.060 |
Why?
|
Parasite Egg Count | 1 | 2022 | 27 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2010 | 1837 | 0.060 |
Why?
|
Oceans and Seas | 1 | 2023 | 50 | 0.060 |
Why?
|
Pain Measurement | 3 | 1999 | 3420 | 0.060 |
Why?
|
Coral Reefs | 1 | 2023 | 19 | 0.060 |
Why?
|
Genetic Heterogeneity | 1 | 2006 | 733 | 0.060 |
Why?
|
5' Untranslated Regions | 1 | 2004 | 249 | 0.060 |
Why?
|
Testosterone | 1 | 2013 | 2419 | 0.060 |
Why?
|
Immunosorbents | 1 | 2022 | 22 | 0.060 |
Why?
|
London | 1 | 2023 | 233 | 0.060 |
Why?
|
Fetal Development | 1 | 2009 | 767 | 0.060 |
Why?
|
Aortic Valve Stenosis | 3 | 1998 | 1965 | 0.050 |
Why?
|
Heart Valve Diseases | 4 | 1999 | 1074 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1076 | 0.050 |
Why?
|
Plant Extracts | 1 | 2006 | 471 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.050 |
Why?
|
Educational Status | 1 | 2011 | 2540 | 0.050 |
Why?
|
Georgia | 1 | 2022 | 186 | 0.050 |
Why?
|
Arthroscopy | 1 | 1989 | 926 | 0.050 |
Why?
|
Splints | 1 | 2023 | 111 | 0.050 |
Why?
|
Double-Blind Method | 5 | 1996 | 12025 | 0.050 |
Why?
|
Mitomycin | 1 | 2003 | 259 | 0.050 |
Why?
|
Nucleotides | 2 | 2016 | 464 | 0.050 |
Why?
|
Systems Theory | 1 | 2002 | 60 | 0.050 |
Why?
|
Binomial Distribution | 1 | 2002 | 25 | 0.050 |
Why?
|
Mesonephros | 1 | 2022 | 41 | 0.050 |
Why?
|
Half-Life | 3 | 2014 | 661 | 0.050 |
Why?
|
Ankle Joint | 2 | 1998 | 411 | 0.050 |
Why?
|
Organometallic Compounds | 1 | 2006 | 665 | 0.050 |
Why?
|
Lentivirus | 1 | 2005 | 503 | 0.050 |
Why?
|
RNA, Fungal | 1 | 2003 | 164 | 0.050 |
Why?
|
Defoliants, Chemical | 1 | 2001 | 6 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2585 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 10259 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2003 | 187 | 0.050 |
Why?
|
Burkholderia cepacia | 1 | 2002 | 22 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11366 | 0.050 |
Why?
|
Rats, Inbred F344 | 4 | 1992 | 862 | 0.050 |
Why?
|
DNA Probes | 1 | 2023 | 560 | 0.050 |
Why?
|
Models, Molecular | 1 | 2012 | 5451 | 0.050 |
Why?
|
Lac Operon | 1 | 2002 | 238 | 0.050 |
Why?
|
Vitamin E | 1 | 2006 | 869 | 0.050 |
Why?
|
bcl-Associated Death Protein | 1 | 2022 | 107 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15520 | 0.050 |
Why?
|
Immune Complex Diseases | 1 | 1981 | 54 | 0.050 |
Why?
|
Mastoid | 1 | 2002 | 92 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 201 | 0.050 |
Why?
|
Burkholderia Infections | 1 | 2002 | 44 | 0.050 |
Why?
|
Stress, Mechanical | 3 | 1996 | 1686 | 0.050 |
Why?
|
Cross Reactions | 1 | 2023 | 841 | 0.050 |
Why?
|
Reference Values | 5 | 2008 | 4982 | 0.050 |
Why?
|
Genetic Vectors | 2 | 2015 | 3424 | 0.050 |
Why?
|
Software | 3 | 2012 | 4441 | 0.050 |
Why?
|
Catalysis | 1 | 2023 | 762 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5692 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2018 | 1730 | 0.050 |
Why?
|
Antibodies, Neoplasm | 2 | 1980 | 286 | 0.050 |
Why?
|
Workplace | 2 | 2006 | 836 | 0.050 |
Why?
|
Bacteriophage lambda | 1 | 2001 | 147 | 0.050 |
Why?
|
Heart Septal Defects, Atrial | 2 | 1996 | 478 | 0.050 |
Why?
|
Hemodynamics | 6 | 1995 | 4196 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 627 | 0.050 |
Why?
|
Infertility, Female | 1 | 2007 | 788 | 0.050 |
Why?
|
3' Untranslated Regions | 2 | 2016 | 513 | 0.050 |
Why?
|
Toxicity Tests | 1 | 2001 | 121 | 0.050 |
Why?
|
RNA Splice Sites | 1 | 2022 | 209 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 2428 | 0.050 |
Why?
|
Doxycycline | 2 | 2012 | 326 | 0.050 |
Why?
|
Hematologic Neoplasms | 2 | 2004 | 1832 | 0.050 |
Why?
|
Inservice Training | 2 | 2018 | 392 | 0.050 |
Why?
|
Calcium | 1 | 2014 | 5755 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3554 | 0.050 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 581 | 0.050 |
Why?
|
Venoms | 1 | 2020 | 91 | 0.050 |
Why?
|
Freeze Drying | 1 | 2020 | 98 | 0.050 |
Why?
|
Receptors, Androgen | 1 | 2007 | 1058 | 0.050 |
Why?
|
Sutures | 2 | 1994 | 299 | 0.050 |
Why?
|
Netherlands | 4 | 2007 | 2170 | 0.050 |
Why?
|
Logistic Models | 5 | 2011 | 13409 | 0.050 |
Why?
|
Air Pollutants | 1 | 1994 | 2816 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 5 | 1981 | 2943 | 0.050 |
Why?
|
Pediatrics | 1 | 1995 | 3475 | 0.050 |
Why?
|
Plankton | 1 | 1999 | 21 | 0.050 |
Why?
|
Yeasts | 1 | 2001 | 284 | 0.050 |
Why?
|
Snails | 1 | 2019 | 22 | 0.050 |
Why?
|
Erythroblasts | 1 | 2020 | 150 | 0.040 |
Why?
|
Rubber | 1 | 1999 | 50 | 0.040 |
Why?
|
Contract Services | 1 | 2000 | 94 | 0.040 |
Why?
|
England | 2 | 2019 | 522 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2007 | 1504 | 0.040 |
Why?
|
Prosthesis-Related Infections | 3 | 1995 | 538 | 0.040 |
Why?
|
Learning | 1 | 2009 | 1711 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 275 | 0.040 |
Why?
|
Pressure | 3 | 1993 | 1203 | 0.040 |
Why?
|
Electrodes | 1 | 2002 | 619 | 0.040 |
Why?
|
Endocarditis, Bacterial | 2 | 1994 | 455 | 0.040 |
Why?
|
Heart Transplantation | 5 | 1992 | 3112 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2003 | 528 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 1981 | 372 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5172 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2011 | 1796 | 0.040 |
Why?
|
Endometriosis | 1 | 2007 | 839 | 0.040 |
Why?
|
Introns | 1 | 2022 | 992 | 0.040 |
Why?
|
Microarray Analysis | 2 | 2012 | 767 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9735 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2004 | 970 | 0.040 |
Why?
|
Plasma | 1 | 2022 | 575 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2002 | 466 | 0.040 |
Why?
|
Aptamers, Nucleotide | 1 | 2020 | 166 | 0.040 |
Why?
|
Acinetobacter | 1 | 2018 | 39 | 0.040 |
Why?
|
Dust | 1 | 2001 | 482 | 0.040 |
Why?
|
New South Wales | 1 | 1998 | 66 | 0.040 |
Why?
|
Games, Experimental | 1 | 1998 | 32 | 0.040 |
Why?
|
Sentinel Surveillance | 1 | 2000 | 281 | 0.040 |
Why?
|
Pedigree | 2 | 2017 | 4642 | 0.040 |
Why?
|
Employment | 1 | 2005 | 1132 | 0.040 |
Why?
|
Health Facilities | 1 | 2003 | 572 | 0.040 |
Why?
|
RecQ Helicases | 1 | 2018 | 54 | 0.040 |
Why?
|
Dogs | 2 | 2022 | 3912 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2021 | 980 | 0.040 |
Why?
|
Air Pollution | 2 | 2011 | 2286 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 7914 | 0.040 |
Why?
|
Proteomics | 3 | 2018 | 3638 | 0.040 |
Why?
|
Arteriosclerosis | 3 | 1997 | 1092 | 0.040 |
Why?
|
Saliva | 1 | 2022 | 809 | 0.040 |
Why?
|
Axillary Vein | 1 | 1997 | 16 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2018 | 256 | 0.040 |
Why?
|
Northern Territory | 1 | 1997 | 5 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 592 | 0.040 |
Why?
|
Solubility | 1 | 2019 | 1088 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
Axillary Artery | 1 | 1997 | 50 | 0.040 |
Why?
|
Policy Making | 1 | 2001 | 554 | 0.040 |
Why?
|
Spleen | 1 | 2024 | 2362 | 0.040 |
Why?
|
Stomach Neoplasms | 2 | 2001 | 1332 | 0.040 |
Why?
|
Antibiotics, Antitubercular | 1 | 2018 | 104 | 0.040 |
Why?
|
Climate Change | 1 | 2023 | 418 | 0.040 |
Why?
|
Acute Disease | 4 | 1996 | 7147 | 0.040 |
Why?
|
Base Pairing | 1 | 2017 | 141 | 0.040 |
Why?
|
Spinal Nerve Roots | 1 | 2017 | 121 | 0.040 |
Why?
|
Muscle Spindles | 1 | 1996 | 14 | 0.040 |
Why?
|
Virus Replication | 1 | 2005 | 2535 | 0.040 |
Why?
|
Age of Onset | 2 | 2015 | 3270 | 0.040 |
Why?
|
Nausea | 1 | 2000 | 674 | 0.040 |
Why?
|
Pulmonary Atelectasis | 1 | 1998 | 145 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 735 | 0.040 |
Why?
|
Glioblastoma | 1 | 2012 | 3481 | 0.040 |
Why?
|
Epilepsy | 1 | 2012 | 3310 | 0.040 |
Why?
|
Suicide, Assisted | 1 | 1997 | 64 | 0.040 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2017 | 103 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2020 | 434 | 0.040 |
Why?
|
Boston | 6 | 1996 | 9312 | 0.040 |
Why?
|
Femoral Vein | 1 | 1997 | 159 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2017 | 3531 | 0.040 |
Why?
|
Consanguinity | 1 | 2018 | 454 | 0.040 |
Why?
|
Embolism, Cholesterol | 1 | 1996 | 34 | 0.040 |
Why?
|
Infant Formula | 1 | 2018 | 199 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 1999 | 711 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 3 | 1997 | 1066 | 0.040 |
Why?
|
Genes, vpr | 1 | 2016 | 20 | 0.040 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2018 | 191 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2006 | 1004 | 0.040 |
Why?
|
Feasibility Studies | 2 | 1999 | 5077 | 0.040 |
Why?
|
Therapeutic Equivalency | 1 | 1996 | 141 | 0.040 |
Why?
|
Electrophysiology | 1 | 1999 | 1308 | 0.040 |
Why?
|
Cough | 1 | 2000 | 555 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2018 | 743 | 0.040 |
Why?
|
Serum Albumin | 1 | 1999 | 675 | 0.040 |
Why?
|
Fertility | 1 | 2001 | 781 | 0.030 |
Why?
|
Mice, Inbred DBA | 3 | 1983 | 642 | 0.030 |
Why?
|
Suspensions | 1 | 1996 | 65 | 0.030 |
Why?
|
Endocardial Cushion Defects | 1 | 1996 | 45 | 0.030 |
Why?
|
Cardioplegic Solutions | 1 | 1996 | 118 | 0.030 |
Why?
|
Subarachnoid Space | 1 | 1996 | 79 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4851 | 0.030 |
Why?
|
Maternal Age | 1 | 2019 | 802 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1958 | 0.030 |
Why?
|
Rifampin | 1 | 2018 | 315 | 0.030 |
Why?
|
Methods | 2 | 1994 | 1129 | 0.030 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 2015 | 20 | 0.030 |
Why?
|
Sleep Stages | 1 | 2000 | 686 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2001 | 544 | 0.030 |
Why?
|
Data Collection | 2 | 1997 | 3339 | 0.030 |
Why?
|
Ganglia | 1 | 2016 | 89 | 0.030 |
Why?
|
Biopsy | 2 | 2018 | 6755 | 0.030 |
Why?
|
Therapy, Computer-Assisted | 1 | 1998 | 271 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1167 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 2887 | 0.030 |
Why?
|
Chromatin Assembly Factor-1 | 1 | 2015 | 20 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 128 | 0.030 |
Why?
|
Ileus | 1 | 2015 | 58 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2003 | 1372 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2017 | 284 | 0.030 |
Why?
|
Metals | 1 | 2020 | 719 | 0.030 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 405 | 0.030 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2133 | 0.030 |
Why?
|
Genetic Variation | 2 | 2018 | 6542 | 0.030 |
Why?
|
Pilot Projects | 2 | 2014 | 8319 | 0.030 |
Why?
|
Mice, Nude | 3 | 2012 | 3689 | 0.030 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 72 | 0.030 |
Why?
|
Equipment Design | 1 | 2003 | 3582 | 0.030 |
Why?
|
Prospective Studies | 9 | 1999 | 53290 | 0.030 |
Why?
|
Thromboembolism | 4 | 1998 | 987 | 0.030 |
Why?
|
Surgical Staplers | 2 | 1992 | 34 | 0.030 |
Why?
|
Myopathies, Nemaline | 1 | 2015 | 72 | 0.030 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2014 | 32 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2015 | 387 | 0.030 |
Why?
|
Intraoperative Care | 2 | 1996 | 767 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 1995 | 419 | 0.030 |
Why?
|
Weight Loss | 1 | 2006 | 2625 | 0.030 |
Why?
|
Prostheses and Implants | 2 | 1994 | 1387 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2086 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 590 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20130 | 0.030 |
Why?
|
Sex Factors | 6 | 1992 | 10400 | 0.030 |
Why?
|
Heart Arrest, Induced | 1 | 1996 | 355 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2018 | 346 | 0.030 |
Why?
|
Immunity | 2 | 1978 | 1014 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 811 | 0.030 |
Why?
|
Volatilization | 1 | 1994 | 82 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2018 | 1202 | 0.030 |
Why?
|
Ribotyping | 1 | 2014 | 35 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
Acetamides | 1 | 1996 | 249 | 0.030 |
Why?
|
Sarcoglycans | 1 | 2014 | 55 | 0.030 |
Why?
|
Astrocytoma | 1 | 1999 | 790 | 0.030 |
Why?
|
Cybernetics | 1 | 1994 | 8 | 0.030 |
Why?
|
Calcinosis | 3 | 1994 | 1499 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
Marfan Syndrome | 1 | 1996 | 240 | 0.030 |
Why?
|
Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
Mice, Inbred mdx | 1 | 2014 | 89 | 0.030 |
Why?
|
Organizational Culture | 1 | 2018 | 510 | 0.030 |
Why?
|
Chordae Tendineae | 1 | 1994 | 44 | 0.030 |
Why?
|
Eflornithine | 1 | 2013 | 31 | 0.030 |
Why?
|
Hypothermia, Induced | 2 | 1996 | 752 | 0.030 |
Why?
|
Plasmodium falciparum | 1 | 2024 | 1732 | 0.030 |
Why?
|
Tetracyclines | 1 | 2014 | 60 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2001 | 1423 | 0.030 |
Why?
|
Tensile Strength | 1 | 1995 | 335 | 0.030 |
Why?
|
Ornithine Decarboxylase | 1 | 2013 | 63 | 0.030 |
Why?
|
Blood Coagulation | 1 | 1980 | 1127 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2020 | 1725 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3130 | 0.030 |
Why?
|
Body Burden | 1 | 2014 | 158 | 0.030 |
Why?
|
Ecology | 1 | 2014 | 106 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1994 | 878 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1994 | 803 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 931 | 0.030 |
Why?
|
Phospholipases | 1 | 1973 | 72 | 0.030 |
Why?
|
Aorta | 2 | 1990 | 2062 | 0.030 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 112 | 0.030 |
Why?
|
Narcotics | 1 | 1996 | 343 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1879 | 0.030 |
Why?
|
Cerebrovascular Circulation | 2 | 2001 | 2732 | 0.030 |
Why?
|
Myocardial Infarction | 4 | 1996 | 11718 | 0.030 |
Why?
|
Catheterization | 2 | 1996 | 1470 | 0.030 |
Why?
|
Reproduction, Asexual | 1 | 2013 | 15 | 0.030 |
Why?
|
Methylation | 1 | 2016 | 1106 | 0.030 |
Why?
|
Disease Progression | 3 | 2015 | 13286 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2001 | 808 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 847 | 0.030 |
Why?
|
Epitopes | 3 | 1977 | 2571 | 0.030 |
Why?
|
Polytetrafluoroethylene | 1 | 1994 | 233 | 0.030 |
Why?
|
Culture | 1 | 1997 | 633 | 0.030 |
Why?
|
Digoxin | 1 | 2014 | 250 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 2014 | 176 | 0.030 |
Why?
|
Femoral Artery | 1 | 1997 | 845 | 0.030 |
Why?
|
Health Personnel | 1 | 2006 | 3219 | 0.030 |
Why?
|
Sheep, Domestic | 1 | 2012 | 49 | 0.030 |
Why?
|
Birth Weight | 1 | 2001 | 2069 | 0.030 |
Why?
|
Injections | 1 | 1996 | 840 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2002 | 1178 | 0.030 |
Why?
|
Follistatin | 1 | 2013 | 141 | 0.030 |
Why?
|
Cardiac Output | 2 | 1994 | 854 | 0.030 |
Why?
|
Genitalia, Male | 1 | 2013 | 84 | 0.030 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 1993 | 30 | 0.030 |
Why?
|
Analgesia, Epidural | 1 | 1996 | 326 | 0.030 |
Why?
|
Yolk Sac | 1 | 2012 | 75 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1996 | 987 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 64 | 0.030 |
Why?
|
Reaction Time | 1 | 1999 | 2098 | 0.030 |
Why?
|
Acetanilides | 1 | 2014 | 168 | 0.030 |
Why?
|
Fatigue | 1 | 2000 | 1531 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2015 | 690 | 0.030 |
Why?
|
Point Mutation | 1 | 2018 | 1624 | 0.030 |
Why?
|
Deoxyguanine Nucleotides | 1 | 2012 | 21 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 764 | 0.030 |
Why?
|
DNA Polymerase I | 1 | 2012 | 38 | 0.030 |
Why?
|
Mice, Inbred Strains | 4 | 1988 | 1828 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1851 | 0.030 |
Why?
|
Europe | 1 | 1999 | 3338 | 0.030 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2012 | 44 | 0.030 |
Why?
|
Weight-Bearing | 1 | 1995 | 515 | 0.030 |
Why?
|
Fungi | 1 | 1995 | 327 | 0.030 |
Why?
|
DNA Polymerase beta | 1 | 2012 | 20 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1617 | 0.030 |
Why?
|
Central Nervous System Neoplasms | 1 | 2001 | 895 | 0.030 |
Why?
|
Erythema Chronicum Migrans | 1 | 1992 | 47 | 0.030 |
Why?
|
Motor Activity | 1 | 2002 | 2715 | 0.030 |
Why?
|
Decerebrate State | 1 | 1992 | 43 | 0.030 |
Why?
|
Running | 1 | 2017 | 480 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1996 | 1084 | 0.030 |
Why?
|
Antigens | 1 | 2018 | 1466 | 0.030 |
Why?
|
Turtles | 1 | 1992 | 40 | 0.030 |
Why?
|
Hindlimb | 1 | 2014 | 504 | 0.030 |
Why?
|
Community-Acquired Infections | 1 | 1996 | 465 | 0.030 |
Why?
|
Heart Aneurysm | 1 | 1992 | 120 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 1994 | 498 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2019 | 1547 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 988 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2017 | 2726 | 0.030 |
Why?
|
Evaluation Studies as Topic | 2 | 1996 | 1681 | 0.030 |
Why?
|
Pyrophosphatases | 1 | 2012 | 137 | 0.030 |
Why?
|
Disability Evaluation | 1 | 1999 | 1828 | 0.020 |
Why?
|
Heart Atria | 3 | 1994 | 1356 | 0.020 |
Why?
|
DNA Polymerase II | 1 | 2012 | 107 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2016 | 1401 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2012 | 293 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 908 | 0.020 |
Why?
|
Collateral Circulation | 1 | 1972 | 287 | 0.020 |
Why?
|
Heart Septum | 1 | 1992 | 312 | 0.020 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 494 | 0.020 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 217 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35425 | 0.020 |
Why?
|
Lung | 2 | 2001 | 9857 | 0.020 |
Why?
|
Endocarditis | 1 | 1995 | 349 | 0.020 |
Why?
|
Healthy Worker Effect | 1 | 2010 | 29 | 0.020 |
Why?
|
DNA Glycosylases | 1 | 2012 | 128 | 0.020 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 297 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1996 | 2029 | 0.020 |
Why?
|
Nitrofurazone | 1 | 2010 | 1 | 0.020 |
Why?
|
Blotting, Far-Western | 1 | 2010 | 4 | 0.020 |
Why?
|
4-Nitroquinoline-1-oxide | 1 | 2010 | 20 | 0.020 |
Why?
|
Zinc | 1 | 1995 | 684 | 0.020 |
Why?
|
Biophysics | 2 | 2004 | 383 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2016 | 1085 | 0.020 |
Why?
|
Genome, Human | 2 | 2016 | 4420 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2012 | 270 | 0.020 |
Why?
|
Organ Size | 2 | 2013 | 2251 | 0.020 |
Why?
|
Motion Perception | 1 | 1995 | 408 | 0.020 |
Why?
|
DNA Primers | 1 | 1995 | 2891 | 0.020 |
Why?
|
Epilepsy, Generalized | 1 | 2012 | 174 | 0.020 |
Why?
|
Body Composition | 1 | 2020 | 2402 | 0.020 |
Why?
|
Cats | 1 | 1992 | 1000 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 1992 | 455 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 1992 | 1162 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1996 | 685 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2274 | 0.020 |
Why?
|
Evoked Potentials | 1 | 1996 | 1056 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 1983 | 329 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2014 | 1341 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2017 | 13991 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2015 | 972 | 0.020 |
Why?
|
Heel | 1 | 1990 | 36 | 0.020 |
Why?
|
Breast Feeding | 1 | 2018 | 1338 | 0.020 |
Why?
|
Maximum Allowable Concentration | 1 | 2009 | 62 | 0.020 |
Why?
|
Valine | 1 | 2011 | 413 | 0.020 |
Why?
|
Health Resources | 1 | 1996 | 911 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 1996 | 1133 | 0.020 |
Why?
|
Arthroscopes | 1 | 1989 | 11 | 0.020 |
Why?
|
Probability | 2 | 2009 | 2506 | 0.020 |
Why?
|
Genes, ras | 1 | 2012 | 690 | 0.020 |
Why?
|
Hemarthrosis | 1 | 1989 | 38 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2015 | 2421 | 0.020 |
Why?
|
Germany | 1 | 1992 | 862 | 0.020 |
Why?
|
Nerve Block | 1 | 1996 | 644 | 0.020 |
Why?
|
Aortic Diseases | 2 | 1997 | 743 | 0.020 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2009 | 25 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2001 | 2624 | 0.020 |
Why?
|
Methylmethacrylate | 1 | 1989 | 44 | 0.020 |
Why?
|
Methionine | 1 | 2011 | 590 | 0.020 |
Why?
|
Neurogenesis | 1 | 2016 | 838 | 0.020 |
Why?
|
Transcriptional Elongation Factors | 1 | 2010 | 166 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5895 | 0.020 |
Why?
|
Health Policy | 1 | 2001 | 2661 | 0.020 |
Why?
|
Thrombectomy | 1 | 1994 | 680 | 0.020 |
Why?
|
Glycoproteins | 1 | 1977 | 2266 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2010 | 288 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2488 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1783 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 1995 | 1178 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2012 | 486 | 0.020 |
Why?
|
Epilepsies, Partial | 1 | 2012 | 436 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4185 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 1989 | 309 | 0.020 |
Why?
|
Animal Experimentation | 1 | 2008 | 45 | 0.020 |
Why?
|
Social Support | 1 | 1998 | 2118 | 0.020 |
Why?
|
Mesenteric Arteries | 1 | 1988 | 183 | 0.020 |
Why?
|
Acne Vulgaris | 1 | 1993 | 302 | 0.020 |
Why?
|
Prevalence | 1 | 2005 | 15221 | 0.020 |
Why?
|
Epidemics | 1 | 2014 | 523 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2014 | 14561 | 0.020 |
Why?
|
Attitude to Health | 1 | 1997 | 2052 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 1990 | 741 | 0.020 |
Why?
|
Endoribonucleases | 1 | 2009 | 229 | 0.020 |
Why?
|
Danazol | 1 | 2007 | 42 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1574 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1097 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 1992 | 546 | 0.020 |
Why?
|
Program Development | 1 | 1994 | 1316 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 1995 | 1162 | 0.020 |
Why?
|
Artifacts | 1 | 1996 | 1904 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Respiratory Tract Diseases | 2 | 1989 | 722 | 0.020 |
Why?
|
Myxoma | 1 | 1988 | 130 | 0.020 |
Why?
|
Back Injuries | 1 | 2007 | 40 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2012 | 850 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1999 | 3188 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 1992 | 1677 | 0.020 |
Why?
|
Bronchi | 1 | 1991 | 840 | 0.020 |
Why?
|
Estrogen Antagonists | 1 | 2007 | 152 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 1998 | 2569 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2012 | 1073 | 0.020 |
Why?
|
Wound Infection | 1 | 1989 | 242 | 0.020 |
Why?
|
Protein Kinases | 1 | 2014 | 1640 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2007 | 107 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1549 | 0.020 |
Why?
|
Echocardiography | 4 | 1992 | 5099 | 0.020 |
Why?
|
Ovulation | 1 | 2007 | 189 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1972 | 1572 | 0.020 |
Why?
|
Immunotherapy | 2 | 2018 | 4446 | 0.020 |
Why?
|
Pleural Neoplasms | 1 | 1991 | 607 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1798 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2634 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 12802 | 0.020 |
Why?
|
Mutagenicity Tests | 1 | 2005 | 46 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2005 | 41 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3203 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2566 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 2 | 1981 | 1369 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.020 |
Why?
|
Lead | 1 | 2011 | 852 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1655 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 2132 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2715 | 0.020 |
Why?
|
Heart Rate | 4 | 2001 | 4092 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6254 | 0.020 |
Why?
|
Heart Diseases | 3 | 1994 | 2789 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1989 | 498 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 1991 | 761 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2765 | 0.020 |
Why?
|
Acetates | 1 | 1986 | 311 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2012 | 1613 | 0.020 |
Why?
|
Computers, Molecular | 1 | 2004 | 14 | 0.020 |
Why?
|
Mesothelioma | 1 | 1991 | 818 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 816 | 0.020 |
Why?
|
Fertilizers | 1 | 2004 | 24 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
Fixatives | 1 | 2004 | 94 | 0.020 |
Why?
|
Macrophages | 2 | 2014 | 5660 | 0.020 |
Why?
|
Aneurysm | 1 | 1988 | 339 | 0.020 |
Why?
|
Graft Occlusion, Vascular | 1 | 1988 | 549 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1991 | 1094 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1988 | 374 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4222 | 0.020 |
Why?
|
Sirolimus | 1 | 2011 | 1565 | 0.020 |
Why?
|
Oscillometry | 1 | 2004 | 147 | 0.020 |
Why?
|
Decision Making | 1 | 1998 | 3888 | 0.010 |
Why?
|
HLA Antigens | 1 | 1990 | 1382 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4424 | 0.010 |
Why?
|
Protective Devices | 1 | 2004 | 71 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 1989 | 530 | 0.010 |
Why?
|
Liver | 1 | 2019 | 7475 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 1992 | 1415 | 0.010 |
Why?
|
Connecticut | 1 | 1984 | 366 | 0.010 |
Why?
|
Coronary Angiography | 2 | 1994 | 4576 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2916 | 0.010 |
Why?
|
Strontium Radioisotopes | 1 | 1983 | 18 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2488 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1978 | 6364 | 0.010 |
Why?
|
Disinfectants | 1 | 2004 | 116 | 0.010 |
Why?
|
Electronics | 1 | 2004 | 322 | 0.010 |
Why?
|
Cortisone | 1 | 1983 | 89 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1991 | 1912 | 0.010 |
Why?
|
Work Schedule Tolerance | 1 | 2006 | 563 | 0.010 |
Why?
|
Morbidity | 2 | 1999 | 1768 | 0.010 |
Why?
|
Biological Transport | 1 | 2007 | 2120 | 0.010 |
Why?
|
tau Proteins | 1 | 2011 | 1868 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1983 | 449 | 0.010 |
Why?
|
Ireland | 1 | 2002 | 161 | 0.010 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1981 | 24 | 0.010 |
Why?
|
Dobutamine | 1 | 1982 | 123 | 0.010 |
Why?
|
Textile Industry | 1 | 2001 | 74 | 0.010 |
Why?
|
Pancreas | 1 | 1988 | 1687 | 0.010 |
Why?
|
Eating | 1 | 1988 | 1536 | 0.010 |
Why?
|
Cost Savings | 1 | 2007 | 925 | 0.010 |
Why?
|
Atrial Fibrillation | 2 | 1998 | 5035 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.010 |
Why?
|
Prognosis | 3 | 2012 | 29060 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1981 | 189 | 0.010 |
Why?
|
Aortic Valve Insufficiency | 2 | 1982 | 579 | 0.010 |
Why?
|
Vietnam | 1 | 2001 | 408 | 0.010 |
Why?
|
Catecholamines | 1 | 1982 | 387 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1972 | 3107 | 0.010 |
Why?
|
Warfarin | 1 | 1989 | 1497 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2002 | 769 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1989 | 1170 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 2002 | 290 | 0.010 |
Why?
|
Documentation | 1 | 2007 | 871 | 0.010 |
Why?
|
Workload | 1 | 2006 | 849 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 1342 | 0.010 |
Why?
|
Power Plants | 1 | 1981 | 119 | 0.010 |
Why?
|
Thrombosis | 1 | 1994 | 2968 | 0.010 |
Why?
|
Survivors | 1 | 2010 | 2291 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2408 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1992 | 2104 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2001 | 264 | 0.010 |
Why?
|
Guinea Pigs | 1 | 2001 | 1386 | 0.010 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2001 | 292 | 0.010 |
Why?
|
Swine | 1 | 1989 | 5918 | 0.010 |
Why?
|
Streptococcal Infections | 2 | 1994 | 638 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1994 | 3922 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1970 | 3476 | 0.010 |
Why?
|
Cerebrovascular Disorders | 2 | 1998 | 1504 | 0.010 |
Why?
|
HIV Infections | 1 | 2005 | 16715 | 0.010 |
Why?
|
Socioeconomic Factors | 2 | 2011 | 7785 | 0.010 |
Why?
|
Immunization | 2 | 1973 | 1256 | 0.010 |
Why?
|
Brain | 3 | 2014 | 26388 | 0.010 |
Why?
|
Antibodies | 2 | 1981 | 2460 | 0.010 |
Why?
|
Rauscher Virus | 1 | 1978 | 31 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1410 | 0.010 |
Why?
|
Partial Pressure | 1 | 1998 | 254 | 0.010 |
Why?
|
AKR murine leukemia virus | 1 | 1977 | 5 | 0.010 |
Why?
|
Moloney murine leukemia virus | 1 | 1978 | 139 | 0.010 |
Why?
|
Respiratory Protective Devices | 1 | 1998 | 45 | 0.010 |
Why?
|
Neoplasms, Experimental | 2 | 1973 | 1276 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1977 | 184 | 0.010 |
Why?
|
Particle Size | 1 | 2001 | 1642 | 0.010 |
Why?
|
Multivariate Analysis | 3 | 1996 | 12244 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1977 | 126 | 0.010 |
Why?
|
Illinois | 1 | 1997 | 119 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1983 | 2242 | 0.010 |
Why?
|
Rabbits | 2 | 1973 | 4894 | 0.010 |
Why?
|
Ventricular Function | 1 | 1998 | 415 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 1987 | 1534 | 0.010 |
Why?
|
Lymphocytes | 2 | 1978 | 2617 | 0.010 |
Why?
|
Combined Modality Therapy | 3 | 1994 | 8642 | 0.010 |
Why?
|
Pulmonary Gas Exchange | 1 | 1998 | 382 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1999 | 1005 | 0.010 |
Why?
|
Plasma Substitutes | 1 | 1976 | 57 | 0.010 |
Why?
|
Postoperative Care | 2 | 1996 | 1487 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1977 | 1157 | 0.010 |
Why?
|
Clavicle | 1 | 1997 | 209 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 1998 | 412 | 0.010 |
Why?
|
Wrist | 1 | 1996 | 224 | 0.010 |
Why?
|
Capsid | 1 | 1977 | 437 | 0.010 |
Why?
|
Dopamine | 1 | 1982 | 1591 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1996 | 694 | 0.010 |
Why?
|
Angina Pectoris | 1 | 1978 | 977 | 0.010 |
Why?
|
Peripheral Vascular Diseases | 1 | 1997 | 550 | 0.010 |
Why?
|
Embolism | 1 | 1997 | 408 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2001 | 1578 | 0.010 |
Why?
|
Catheterization, Peripheral | 1 | 1997 | 345 | 0.010 |
Why?
|
Equipment Failure | 2 | 1989 | 578 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 12961 | 0.010 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 15160 | 0.010 |
Why?
|
Postoperative Period | 1 | 1998 | 1842 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2001 | 20824 | 0.010 |
Why?
|
Curriculum | 1 | 2006 | 3605 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1998 | 1206 | 0.010 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1973 | 133 | 0.010 |
Why?
|
Fetal Proteins | 1 | 1973 | 94 | 0.010 |
Why?
|
Edetic Acid | 1 | 1973 | 275 | 0.010 |
Why?
|
Immune Sera | 1 | 1973 | 641 | 0.010 |
Why?
|
Stroke Volume | 2 | 1998 | 5006 | 0.010 |
Why?
|
Neuraminidase | 1 | 1973 | 210 | 0.010 |
Why?
|
Trypsin | 1 | 1973 | 511 | 0.010 |
Why?
|
Life Tables | 1 | 1992 | 370 | 0.010 |
Why?
|
Sex Distribution | 1 | 1998 | 2297 | 0.010 |
Why?
|
Xenon | 1 | 1972 | 110 | 0.010 |
Why?
|
Thoracotomy | 1 | 1994 | 363 | 0.010 |
Why?
|
Hospital Mortality | 2 | 1998 | 5316 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.010 |
Why?
|
Blood Pressure | 2 | 2001 | 8551 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1980 | 1178 | 0.010 |
Why?
|
Age Distribution | 1 | 1998 | 2902 | 0.010 |
Why?
|
Isoenzymes | 1 | 1996 | 1728 | 0.010 |
Why?
|
Dinitrophenols | 1 | 1970 | 57 | 0.010 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 1970 | 77 | 0.010 |
Why?
|
Hand | 1 | 1996 | 884 | 0.010 |
Why?
|
gamma-Globulins | 1 | 1970 | 124 | 0.010 |
Why?
|
Wales | 1 | 1971 | 85 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1988 | 8949 | 0.010 |
Why?
|
Radioisotopes | 1 | 1972 | 500 | 0.010 |
Why?
|
Nutritional Status | 1 | 1999 | 1609 | 0.010 |
Why?
|
Demography | 2 | 1989 | 1655 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1996 | 1579 | 0.010 |
Why?
|
Haptens | 1 | 1970 | 166 | 0.010 |
Why?
|
Isoantigens | 1 | 1973 | 567 | 0.010 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 1997 | 691 | 0.010 |
Why?
|
Tissue Extracts | 1 | 1970 | 135 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 9955 | 0.010 |
Why?
|
Whooping Cough | 1 | 1971 | 82 | 0.010 |
Why?
|
Population Density | 1 | 1971 | 196 | 0.010 |
Why?
|
Culture Techniques | 1 | 1970 | 554 | 0.010 |
Why?
|
Rosette Formation | 2 | 1981 | 153 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1970 | 324 | 0.010 |
Why?
|
Pleura | 1 | 1991 | 235 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 1970 | 467 | 0.010 |
Why?
|
Emergencies | 1 | 1996 | 1170 | 0.010 |
Why?
|
Accidents | 1 | 1971 | 164 | 0.010 |
Why?
|
Crowding | 1 | 1971 | 145 | 0.010 |
Why?
|
Diaphragm | 1 | 1991 | 349 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 1999 | 1956 | 0.010 |
Why?
|
HLA-A Antigens | 1 | 1990 | 232 | 0.010 |
Why?
|
Cyclosporine | 1 | 1992 | 788 | 0.010 |
Why?
|
Ear Diseases | 1 | 1971 | 170 | 0.010 |
Why?
|
Computers | 1 | 1972 | 612 | 0.010 |
Why?
|
Radiography | 2 | 1992 | 7023 | 0.010 |
Why?
|
Culture Media | 1 | 1970 | 909 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1970 | 1095 | 0.010 |
Why?
|
Estrus | 1 | 1988 | 81 | 0.010 |
Why?
|
HLA-B Antigens | 1 | 1990 | 354 | 0.010 |
Why?
|
Paralysis | 1 | 1990 | 247 | 0.000 |
Why?
|
Methylprednisolone | 1 | 1990 | 387 | 0.000 |
Why?
|
Lectins | 1 | 1970 | 513 | 0.000 |
Why?
|
Antilymphocyte Serum | 1 | 1990 | 492 | 0.000 |
Why?
|
Transplantation, Homologous | 2 | 1992 | 4777 | 0.000 |
Why?
|
HLA-DR Antigens | 1 | 1990 | 645 | 0.000 |
Why?
|
Veterans | 1 | 2001 | 2519 | 0.000 |
Why?
|
Perfusion | 1 | 1972 | 1360 | 0.000 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 1998 | 1537 | 0.000 |
Why?
|
Education | 1 | 1971 | 543 | 0.000 |
Why?
|
Hemolysis | 1 | 1989 | 420 | 0.000 |
Why?
|
Intraoperative Period | 1 | 1988 | 520 | 0.000 |
Why?
|
Immunoglobulins | 1 | 1970 | 881 | 0.000 |
Why?
|
Arteries | 1 | 1992 | 1119 | 0.000 |
Why?
|
Angiography | 1 | 1972 | 1639 | 0.000 |
Why?
|
Echocardiography, Doppler | 1 | 1991 | 935 | 0.000 |
Why?
|
Pericardium | 1 | 1991 | 667 | 0.000 |
Why?
|
Kidney Neoplasms | 2 | 1973 | 4262 | 0.000 |
Why?
|
Laparotomy | 1 | 1989 | 473 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1973 | 1348 | 0.000 |
Why?
|
Congenital Abnormalities | 1 | 1971 | 707 | 0.000 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1996 | 2073 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15078 | 0.000 |
Why?
|
Antigens, Neoplasm | 1 | 1973 | 1988 | 0.000 |
Why?
|
Saphenous Vein | 1 | 1988 | 532 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1972 | 1739 | 0.000 |
Why?
|
Spermatozoa | 1 | 1988 | 625 | 0.000 |
Why?
|
Heart Failure | 1 | 1987 | 10895 | 0.000 |
Why?
|
Anticoagulants | 1 | 1998 | 4600 | 0.000 |
Why?
|
Electrocardiography | 1 | 1996 | 6442 | 0.000 |
Why?
|
Length of Stay | 1 | 1996 | 6311 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1992 | 2269 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1982 | 326 | 0.000 |
Why?
|
Social Class | 1 | 1971 | 1997 | 0.000 |
Why?
|
Graft Survival | 1 | 1992 | 3737 | 0.000 |
Why?
|
Binding Sites, Antibody | 1 | 1981 | 349 | 0.000 |
Why?
|
Ascitic Fluid | 1 | 1981 | 192 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1972 | 3280 | 0.000 |
Why?
|
Influenza, Human | 1 | 1971 | 1479 | 0.000 |
Why?
|
Ultrasonography | 1 | 1992 | 5984 | 0.000 |
Why?
|
Myocardium | 1 | 1972 | 4772 | 0.000 |
Why?
|
Multiple Myeloma | 1 | 1997 | 5181 | 0.000 |
Why?
|
Pneumonia | 1 | 1971 | 2133 | 0.000 |
Why?
|
Preoperative Care | 1 | 1988 | 2251 | 0.000 |
Why?
|
Intensive Care Units | 1 | 1972 | 3680 | 0.000 |
Why?
|
Tuberculosis | 1 | 1971 | 1912 | 0.000 |
Why?
|
Electroencephalography | 1 | 1992 | 6151 | 0.000 |
Why?
|
Hemorrhage | 1 | 1989 | 3461 | 0.000 |
Why?
|
Obesity | 1 | 1999 | 12746 | 0.000 |
Why?
|
Life Expectancy | 1 | 1981 | 1184 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9274 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 11525 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1978 | 4561 | 0.000 |
Why?
|